Regulation	O
of	O
the	O
interleukin-1	B-DNA
beta	I-DNA
(	I-DNA
IL-1	I-DNA
beta	I-DNA
)	I-DNA
gene	I-DNA
by	O
mycobacterial	B-protein
components	I-protein
and	O
lipopolysaccharide	O
is	O
mediated	O
by	O
two	O
nuclear	B-DNA
factor-IL6	I-DNA
motifs	I-DNA
.	O

The	O
cytokines	O
interleukin-1	O
beta	O
(	O
IL-1	B-protein
beta	I-protein
)	O
and	O
tumor	O
necrosis	O
factor	O
alpha	O
(	O
TNF-alpha	B-protein
)	O
are	O
released	O
by	O
mononuclear	B-cell_type
phagocytes	I-cell_type
in	O
vitro	O
after	O
stimulation	O
with	O
mycobacteria	O
and	O
are	O
considered	O
to	O
mediate	O
pathophysiologic	O
events	O
,	O
including	O
granuloma	O
formation	O
and	O
systemic	O
symptoms	O
.	O

We	O
demonstrated	O
that	O
the	O
Mycobacterium	O
tuberculosis	O
cell	O
wall	O
component	O
lipoarabinomannan	O
(	O
LAM	O
)	O
is	O
a	O
very	O
potent	O
inducer	O
of	O
IL-1	B-DNA
beta	I-DNA
gene	I-DNA
expression	O
in	O
human	B-cell_type
monocytes	I-cell_type
and	O
investigated	O
the	O
mechanism	O
of	O
this	O
effect	O
.	O

We	O
localized	O
the	O
LAM-	O
,	O
lipopolysaccharide	O
(	O
LPS	O
)	O
-	O
,	O
and	O
TNF-alpha	B-protein
-inducible	B-DNA
promoter	I-DNA
activity	O
to	O
a	O
-131/+15	O
(	O
positions	O
-131	O
to	O
+15	O
)	O
DNA	O
fragment	O
of	O
the	O
IL-1	B-DNA
beta	I-DNA
gene	I-DNA
by	O
deletion	O
analysis	O
and	O
chloramphenicol	B-protein
acetyltransferase	I-protein
assay	O
.	O

Within	O
this	O
DNA	O
fragment	O
,	O
there	O
were	O
two	O
novel	O
9-bp	O
motifs	O
(	O
-90/-82	O
and	O
-40/-32	O
)	O
with	O
high	O
homology	O
to	O
the	O
nuclear	B-DNA
factor-IL6	I-DNA
(	I-DNA
NF-IL6	I-DNA
)	I-DNA
binding	I-DNA
site	I-DNA
.	O

Site-directed	O
mutagenesis	O
demonstrated	O
that	O
the	O
two	O
NF-IL-6	B-DNA
motifs	I-DNA
could	O
be	O
independently	O
activated	O
by	O
LAM	O
,	O
LPS	O
,	O
or	O
TNF-alpha	B-protein
and	O
that	O
they	O
acted	O
in	O
an	O
orientation-independent	O
manner	O
.	O

DNA	O
mobility	O
shift	O
assay	O
revealed	O
specific	O
binding	O
of	O
nuclear	B-protein
protein	I-protein
(	O
s	O
)	O
from	O
LAM-	B-cell_line
,	I-cell_line
LPS-	I-cell_line
,	I-cell_line
or	I-cell_line
TNF-alpha-	I-cell_line
stimulated	I-cell_line
THP-1	I-cell_line
cells	I-cell_line
to	O
the	O
NF-IL6	O
motifs	O
.	O

We	O
conclude	O
that	O
the	O
two	O
NF-IL6	B-DNA
sites	I-DNA
mediate	O
induction	O
of	O
IL-1	B-protein
beta	I-protein
in	O
response	O
to	O
the	O
stimuli	O
LAM	O
,	O
LPS	O
,	O
and	O
TNF-alpha	B-protein
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
June	NULL
1993	NULL
,	NULL
p.	NULL
3831-3837	NULL
0270-7306/93/063831-07	NULL
$	NULL
02.00/0	NULL
Copyright	NULL
©	NULL
1993	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

13	NULL
,	NULL
No	NULL
.	NULL

6	NULL
Regulation	NULL
of	NULL
the	NULL
Interleukin-1B	NULL
(	NULL
IL-1B	NULL
)	NULL
Gene	NULL
by	NULL
Mycobacterial	NULL
Components	NULL
and	NULL
Lipopolysaccharide	NULL
Is	NULL
Mediated	NULL
by	NULL
Two	NULL
Nuclear	NULL
Factor-IL6	NULL
Motifs	NULL
YIHONG	NULL
ZHANG	NULL
anp	NULL
WILLIAM	NULL
N.	NULL
ROM*	NULL
Division	NULL
of	NULL
Pulmonary	NULL
and	NULL
Critical	NULL
Care	NULL
Medicine	NULL
,	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Environmental	NULL
Medicine	NULL
,	NULL
and	NULL
Chest	NULL
Service	NULL
,	NULL
Bellevue	NULL
Hospital	NULL
Center	NULL
,	NULL
New	NULL
York	NULL
University	NULL
Medical	NULL
Center	NULL
,	NULL
550	NULL
First	NULL
Avenue	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10016	NULL
Received	NULL
2	NULL
December	NULL
1992/Returned	NULL
for	NULL
modification	NULL
6	NULL
January	NULL
1993/Accepted	NULL
8	NULL
March	NULL
1993	NULL
The	NULL
cytokines	NULL
interleukin-16	NULL
(	NULL
IL-1B	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
are	NULL
released	NULL
by	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
vitro	NULL
after	NULL
stimulation	NULL
with	NULL
mycobacteria	NULL
and	NULL
are	NULL
considered	NULL
to	NULL
mediate	NULL
pathophysiologic	NULL
events	NULL
,	NULL
including	NULL
granuloma	NULL
formation	NULL
and	NULL
systemic	NULL
symptoms	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
the	NULL
Mycobacterium	NULL
tuberculosis	NULL
cell	NULL
wall	NULL
component	NULL
lipoarabinomannan	NULL
(	NULL
LAM	NULL
)	NULL
is	NULL
a	NULL
very	NULL
potent	NULL
inducer	NULL
of	NULL
IL-1B	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
monocytes	NULL
and	NULL
investigated	NULL
the	NULL
mechanism	NULL
of	NULL
this	NULL
effect	NULL
.	NULL

We	NULL
localized	NULL
the	NULL
LAM-	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
-	NULL
,	NULL
and	NULL
TNF-c-inducible	NULL
promoter	NULL
activity	NULL
to	NULL
a	NULL
-131/+15	NULL
(	NULL
positions	NULL
-131	NULL
to	NULL
+15	NULL
)	NULL
DNA	NULL
fragment	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
by	NULL
deletion	NULL
analysis	NULL
and	NULL
chloramphenicol	NULL
acetyltransferase	NULL
assay	NULL
.	NULL

Within	NULL
this	NULL
DNA	NULL
fragment	NULL
,	NULL
there	NULL
were	NULL
two	NULL
novel	NULL
9-bp	NULL
motifs	NULL
(	NULL
-90/-82	NULL
and	NULL
-40/-32	NULL
)	NULL
with	NULL
high	NULL
homology	NULL
to	NULL
the	NULL
nuclear	NULL
factor-IL6	NULL
(	NULL
NF-IL6	NULL
)	NULL
binding	NULL
site	NULL
.	NULL

Site-directed	NULL
mutagenesis	NULL
demonstrated	NULL
that	NULL
the	NULL
two	NULL
NF-IL-6	NULL
motifs	NULL
could	NULL
be	NULL
independently	NULL
activated	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
and	NULL
that	NULL
they	NULL
acted	NULL
in	NULL
an	NULL
orientation-independent	NULL
manner	NULL
.	NULL

DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
revealed	NULL
specific	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
from	NULL
LAM-	NULL
,	NULL
LPS-	NULL
,	NULL
or	NULL
TNF-o-stimulated	NULL
THP-1	NULL
cells	NULL
to	NULL
the	NULL
NF-IL6	NULL
motifs	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
the	NULL
two	NULL
NF-IL6	NULL
sites	NULL
mediate	NULL
induction	NULL
of	NULL
IL-1§	NULL
in	NULL
response	NULL
to	NULL
the	NULL
stimuli	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
.	NULL

Tuberculosis	NULL
is	NULL
characterized	NULL
by	NULL
granuloma	NULL
formation	NULL
with	NULL
caseation	NULL
necrosis	NULL
and	NULL
systemic	NULL
symptoms	NULL
of	NULL
weight	NULL
loss	NULL
,	NULL
fever	NULL
,	NULL
and	NULL
night	NULL
sweats	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Animal	NULL
models	NULL
demonstrate	NULL
cytokines	NULL
in	NULL
the	NULL
granulomas	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
experiments	NULL
with	NULL
mononuclear	NULL
phagocytes	NULL
have	NULL
established	NULL
that	NULL
Mycobacterium	NULL
tuberculosis	NULL
stimulates	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
(	NULL
5	NULL
,	NULL
6	NULL
,	NULL
25	NULL
,	NULL
33	NULL
,	NULL
40	NULL
,	NULL
41	NULL
)	NULL
.	NULL

Interleukin-1B	NULL
(	NULL
IL-1B	NULL
)	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-a	NULL
)	NULL
are	NULL
the	NULL
two	NULL
major	NULL
inflammatory	NULL
mediators	NULL
released	NULL
in	NULL
vitro	NULL
by	NULL
mycobacteria	NULL
(	NULL
5	NULL
,	NULL
13	NULL
)	NULL
.	NULL

IL-1	NULL
$	NULL
is	NULL
chemotactic	NULL
for	NULL
lymphocytes	NULL
and	NULL
can	NULL
activate	NULL
CD4*	NULL
helper-inducer	NULL
T	NULL
lymphocytes	NULL
,	NULL
causing	NULL
them	NULL
to	NULL
proliferate	NULL
and	NULL
release	NULL
gamma	NULL
interferon	NULL
(	NULL
IFN-y	NULL
)	NULL
(	NULL
22	NULL
)	NULL
.	NULL

IL-1	NULL
and	NULL
IFN-y	NULL
stimulate	NULL
macrophages	NULL
to	NULL
release	NULL
TNF-	NULL
«	NULL
,	NULL
which	NULL
can	NULL
also	NULL
stimulate	NULL
the	NULL
release	NULL
of	NULL
IL-1B	NULL
(	NULL
28	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
recombinant	NULL
IL-1	NULL
impregnated	NULL
in	NULL
ethyl	NULL
vinyl	NULL
disks	NULL
revealed	NULL
that	NULL
IL-1	NULL
could	NULL
directly	NULL
induce	NULL
a	NULL
granulomatous	NULL
response	NULL
in	NULL
juxtaposition	NULL
to	NULL
the	NULL
implanted	NULL
disks	NULL
(	NULL
17	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Pulmonary	NULL
granulomas	NULL
induced	NULL
in	NULL
mice	NULL
by	NULL
the	NULL
intratracheal	NULL
injection	NULL
of	NULL
antigen-coated	NULL
beads	NULL
were	NULL
excised	NULL
,	NULL
and	NULL
aqueous	NULL
extracts	NULL
of	NULL
the	NULL
granulomata	NULL
contained	NULL
high	NULL
levels	NULL
of	NULL
IL-1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Studies	NULL
by	NULL
Kunkel	NULL
and	NULL
colleagues	NULL
demonstrated	NULL
that	NULL
IL-1f	NULL
is	NULL
the	NULL
dominant	NULL
cytokine	NULL
in	NULL
early	NULL
schistosomal	NULL
granuloma	NULL
develop-ment	NULL
,	NULL
followed	NULL
temporally	NULL
by	NULL
TNF-a	NULL
(	NULL
27	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
IL-1	NULL
may	NULL
be	NULL
more	NULL
important	NULL
to	NULL
the	NULL
early	NULL
cellular	NULL
recruitment	NULL
of	NULL
inflammatory	NULL
cells	NULL
and	NULL
their	NULL
activation	NULL
,	NULL
while	NULL
TNF-a	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
continued	NULL
organization	NULL
of	NULL
the	NULL
mature	NULL
granulomatous	NULL
lesion	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
is	NULL
achieved	NULL
by	NULL
a	NULL
number	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
from	NULL
gram-negative	NULL
bacteria	NULL
,	NULL
phorbol	NULL
esters	NULL
,	NULL
silica	NULL
,	NULL
and	NULL
other	NULL
bacterial	NULL
products	NULL
(	NULL
18	NULL
,	NULL
30	NULL
,	NULL
36	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Although	NULL
mycobacteria	NULL
do	NULL
not	NULL
possess	NULL
LPS	NULL
,	NULL
the	NULL
cell	NULL
wall	NULL
of	NULL
M.	NULL
tuberculosis	NULL
contains	NULL
a	NULL
complex	NULL
lipid	NULL
glycoprotein	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

3831	NULL
called	NULL
lipoarabinomannan	NULL
(	NULL
LAM	NULL
)	NULL
which	NULL
shares	NULL
many	NULL
phys-icochemical	NULL
properties	NULL
with	NULL
LPS	NULL
(	NULL
5	NULL
,	NULL
12	NULL
)	NULL
.	NULL

The	NULL
cell	NULL
wall	NULL
backbone	NULL
of	NULL
LAM	NULL
is	NULL
complemented	NULL
by	NULL
phenolic	NULL
glycolipids	NULL
,	NULL
mycolic	NULL
acids	NULL
,	NULL
arabinogalactan	NULL
,	NULL
peptidoglycan	NULL
,	NULL
and	NULL
manno-phosphoinositides	NULL
.	NULL

However	NULL
,	NULL
the	NULL
most	NULL
antigenic	NULL
and	NULL
consequently	NULL
biologically	NULL
active	NULL
component	NULL
is	NULL
LAM	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
stimulating	NULL
cytokine	NULL
release	NULL
,	NULL
LAM	NULL
inhibits	NULL
IFN-y	NULL
activation	NULL
of	NULL
macrophages	NULL
and	NULL
protein-antigen	NULL
processing	NULL
by	NULL
antigen-presenting	NULL
cells	NULL
and	NULL
can	NULL
suppress	NULL
T-lym-phocyte	NULL
proliferation	NULL
in	NULL
vitro	NULL
in	NULL
response	NULL
to	NULL
mitogens	NULL
and	NULL
specific	NULL
antigens	NULL
(	NULL
5	NULL
,	NULL
32	NULL
,	NULL
39	NULL
)	NULL
.	NULL

Barnes	NULL
and	NULL
colleagues	NULL
demonstrated	NULL
that	NULL
the	NULL
phosphoinositol	NULL
component	NULL
anchoring	NULL
LAM	NULL
to	NULL
the	NULL
cell	NULL
wall	NULL
was	NULL
critical	NULL
for	NULL
LAM	NULL
's	NULL
ability	NULL
to	NULL
stimulate	NULL
cytokine	NULL
release	NULL
,	NULL
because	NULL
a	NULL
deacylated	NULL
LAM	NULL
lacking	NULL
this	NULL
component	NULL
was	NULL
unable	NULL
to	NULL
stimulate	NULL
cytokine	NULL
mRNA	NULL
expression	NULL
(	NULL
5	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Chatterjee	NULL
and	NULL
colleagues	NULL
demonstrated	NULL
that	NULL
LAM	NULL
from	NULL
the	NULL
attenuated	NULL
strain	NULL
H37Ra	NULL
stimulated	NULL
significantly	NULL
more	NULL
TNF-a	NULL
in	NULL
vitro	NULL
from	NULL
murine	NULL
peritoneal	NULL
or	NULL
bone	NULL
marrow	NULL
macrophages	NULL
than	NULL
LAM	NULL
from	NULL
the	NULL
more	NULL
virulent	NULL
Erdman	NULL
strain	NULL
(	NULL
12	NULL
)	NULL
.	NULL

The	NULL
LAM	NULL
from	NULL
the	NULL
Erdman	NULL
strain	NULL
was	NULL
shown	NULL
to	NULL
have	NULL
mannose	NULL
moieties	NULL
capping	NULL
the	NULL
arabinan	NULL
side	NULL
chains	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
LAM	NULL
from	NULL
strain	NULL
H37Ra	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
further	NULL
dissect	NULL
the	NULL
host	NULL
immune	NULL
response	NULL
to	NULL
tuberculosis	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
mechanism	NULL
of	NULL
cytokine	NULL
gene	NULL
regulation	NULL
in	NULL
mononuclear	NULL
phagocyte	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
the	NULL
M.	NULL
tuberculosis	NULL
component	NULL
,	NULL
the	NULL
purified	NULL
cell	NULL
wall	NULL
,	NULL
LAM	NULL
.	NULL

We	NULL
isolated	NULL
a	NULL
1.145-kb	NULL
fragment	NULL
of	NULL
the	NULL
5	NULL
IL-18B	NULL
genomic	NULL
DNA	NULL
and	NULL
evaluated	NULL
the	NULL
responsiveness	NULL
of	NULL
this	NULL
fragment	NULL
to	NULL
stimulation	NULL
with	NULL
LAM	NULL
and	NULL
LPS	NULL
.	NULL

Interestingly	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
nuclear	NULL
factor-IL6	NULL
(	NULL
NF-IL6	NULL
)	NULL
binding	NULL
sites	NULL
were	NULL
the	NULL
major	NULL
cis-acting	NULL
elements	NULL
for	NULL
stimulation	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
deletion	NULL
analysis	NULL
and	NULL
site-directed	NULL
mutagenesis	NULL
studies	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
NF-IL6	NULL
site	NULL
was	NULL
enhanced	NULL
by	NULL
these	NULL
stimuli	NULL
.	NULL

3832	NULL
ZHANG	NULL
AND	NULL
ROM	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
Materials	NULL
.	NULL

O55	NULL
LPS	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
.	NULL

Recombinant	NULL
human	NULL
TNF-	NULL
«	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
4.8	NULL
x	NULL
10	NULL
``	NULL
U/ml	NULL
)	NULL
was	NULL
supplied	NULL
by	NULL
M.	NULL
Tsujimoto	NULL
,	NULL
Suntory	NULL
Institute	NULL
for	NULL
Biomedical	NULL
Research	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
.	NULL

LAM	NULL
was	NULL
from	NULL
a	NULL
laboratory	NULL
attenuated	NULL
strain	NULL
of	NULL
M.	NULL
tuberculosis	NULL
.	NULL

H37Ra	NULL
was	NULL
provided	NULL
by	NULL
P.	NULL
Brennan	NULL
,	NULL
Colorado	NULL
State	NULL
University	NULL
,	NULL
Ft.	NULL
Collins	NULL
.	NULL

Culture	NULL
filtrate	NULL
from	NULL
an	NULL
M.	NULL
tuberculosis	NULL
Erdman	NULL
strain	NULL
that	NULL
was	NULL
free	NULL
of	NULL
LAM	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
(	NULL
SDS-PAGE	NULL
)	NULL
and	NULL
Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
after	NULL
anion-exchange	NULL
and	NULL
molecular	NULL
size	NULL
chromatography	NULL
was	NULL
provided	NULL
by	NULL
P.	NULL
Brennan	NULL
.	NULL

A	NULL
Mycobacterium	NULL
bovis	NULL
65-kDa	NULL
recombinant	NULL
heat	NULL
shock	NULL
protein	NULL
(	NULL
HSP-65kD	NULL
)	NULL
was	NULL
provided	NULL
by	NULL
R.	NULL
Van	NULL
der	NULL
Zee	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Public	NULL
Health	NULL
and	NULL
Environmental	NULL
Protection	NULL
,	NULL
Bilthoven	NULL
,	NULL
The	NULL
Netherlands	NULL
.	NULL

The	NULL
LAM	NULL
had	NULL
been	NULL
eluted	NULL
through	NULL
Detoxi-Gel	NULL
with	NULL
sterile	NULL
,	NULL
pyrogen-free	NULL
water	NULL
and	NULL
was	NULL
stored	NULL
in	NULL
pyrogen-free	NULL
vials	NULL
from	NULL
which	NULL
any	NULL
contaminating	NULL
LPS	NULL
had	NULL
been	NULL
removed	NULL
.	NULL

Only	NULL
pyrogen-free	NULL
water	NULL
was	NULL
used	NULL
in	NULL
reconstitution	NULL
of	NULL
this	NULL
mate-rial	NULL
.	NULL

Evaluation	NULL
of	NULL
tuberculosis	NULL
reagents	NULL
,	NULL
including	NULL
LAM	NULL
,	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
gram-negative	NULL
bacterial	NULL
endotoxin	NULL
was	NULL
done	NULL
with	NULL
an	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
(	NULL
E-Toxate	NULL
kit	NULL
;	NULL
Sigma	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

Human	NULL
myelomonocytic	NULL
leukemic	NULL
cell	NULL
line	NULL
THP-1	NULL
cells	NULL
were	NULL
purchased	NULL
from	NULL
the	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
,	NULL
Rockville	NULL
,	NULL
Md	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
maintained	NULL
in	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
.	NULL

Peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
(	NULL
PBMs	NULL
)	NULL
from	NULL
purified	NULL
protein	NULL
derivative-negative	NULL
healthy	NULL
volunteers	NULL
were	NULL
isolated	NULL
by	NULL
centrifugation	NULL
over	NULL
Ficoll-Hypaque	NULL
(	NULL
Flow	NULL
Laboratories	NULL
)	NULL
,	NULL
washed	NULL
,	NULL
and	NULL
seeded	NULL
onto	NULL
the	NULL
plastic	NULL
surface	NULL
of	NULL
a	NULL
175-cm*	NULL
flask	NULL
in	NULL
RPMI	NULL
1640	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
for	NULL
2	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
flask	NULL
was	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
RPMI	NULL
1640	NULL
to	NULL
remove	NULL
nonadherent	NULL
cells	NULL
,	NULL
and	NULL
the	NULL
monocyte-enriched	NULL
population	NULL
(	NULL
>	NULL
90	NULL
%	NULL
PBMs	NULL
)	NULL
was	NULL
detached	NULL
by	NULL
scraping	NULL
with	NULL
a	NULL
rubber	NULL
policeman	NULL
.	NULL

Isolation	NULL
of	NULL
RNA	NULL
and	NULL
Northern	NULL
(	NULL
RNA	NULL
)	NULL
blot	NULL
analysis	NULL
.	NULL

Human	NULL
PBMs	NULL
were	NULL
stimulated	NULL
for	NULL
5	NULL
h	NULL
,	NULL
collected	NULL
by	NULL
centrifugation	NULL
,	NULL
and	NULL
lysed	NULL
by	NULL
addition	NULL
of	NULL
5.5	NULL
M	NULL
guanidinium	NULL
isothiocyanate	NULL
buffer	NULL
.	NULL

Cytoplasmic	NULL
RNA	NULL
was	NULL
isolated	NULL
through	NULL
CsCl	NULL
;	NULL
gradient	NULL
ultracentrifugation	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
the	NULL
extracted	NULL
RNA	NULL
were	NULL
fractionated	NULL
by	NULL
electrophoresis	NULL
through	NULL
a	NULL
1	NULL
%	NULL
agar-ose-6	NULL
%	NULL
formaldehyde	NULL
denaturing	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
filter	NULL
(	NULL
BA	NULL
85	NULL
;	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
)	NULL
,	NULL
and	NULL
baked	NULL
at	NULL
80°C	NULL
for	NULL
2	NULL
h.	NULL
The	NULL
baked	NULL
filter	NULL
was	NULL
incubated	NULL
in	NULL
40	NULL
ml	NULL
of	NULL
prehybridization	NULL
solution	NULL
{	NULL
50	NULL
%	NULL
formamide	NULL
,	NULL
0.5	NULL
%	NULL
SDS	NULL
,	NULL
10x	NULL
Denhardt	NULL
's	NULL
solution	NULL
,	NULL
2.5	NULL
%	NULL
herring	NULL
sperm	NULL
DNA	NULL
,	NULL
and	NULL
4	NULL
%	NULL
SSPE	NULL
[	NULL
1x	NULL
SSPE	NULL
is	NULL
0.18	NULL
M	NULL
NaCl	NULL
,	NULL
10	NULL
mM	NULL
NaPO	NULL
,	NULL
,	NULL
and	NULL
1	NULL
mM	NULL
EDTA	NULL
(	NULL
pH	NULL
7.7	NULL
)	NULL
]	NULL
}	NULL
at	NULL
42°C	NULL
for	NULL
6	NULL
to	NULL
12	NULL
h.	NULL
An	NULL
IL-1B	NULL
cDNA	NULL
probe	NULL
(	NULL
S.	NULL
Gillis	NULL
,	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
Wash.	NULL
)	NULL
,	NULL
a	NULL
TNF-	NULL
«	NULL
cDNA	NULL
probe	NULL
(	NULL
Genentech	NULL
,	NULL
South	NULL
San	NULL
Francisco	NULL
,	NULL
Calif.	NULL
)	NULL
,	NULL
and	NULL
a	NULL
pHe7	NULL
cDNA	NULL
probe	NULL
were	NULL
radiolabeled	NULL
with	NULL
[	NULL
a-	NULL
``	NULL
°P	NULL
]	NULL
dCTP	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
3,000	NULL
Ci/mmol	NULL
;	NULL
New	NULL
England	NULL
Nuclear	NULL
)	NULL
by	NULL
nick	NULL
translation	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
at	NULL
42°C	NULL
for	NULL
10	NULL
h.	NULL
The	NULL
filter	NULL
was	NULL
then	NULL
washed	NULL
in	NULL
2x	NULL
SSC	NULL
(	NULL
1x	NULL
SSC	NULL
is	NULL
0.15	NULL
M	NULL
NaCl	NULL
plus	NULL
0.015	NULL
M	NULL
sodium	NULL
citrate	NULL
)	NULL
-0.5	NULL
%	NULL
SDS	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
20	NULL
min	NULL
and	NULL
then	NULL
was	NULL
washed	NULL
in	NULL
0.1	NULL
%	NULL
SSC-0.5	NULL
%	NULL
SDS	NULL
at	NULL
65°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Autoradiography	NULL
was	NULL
performed	NULL
at	NULL
-70°C	NULL
.	NULL

Screening	NULL
of	NULL
human	NULL
genomic	NULL
library	NULL
and	NULL
plasmid	NULL
construc-tion	NULL
.	NULL

A	NULL
human	NULL
genomic	NULL
library	NULL
(	NULL
Clontech	NULL
)	NULL
was	NULL
screened	NULL
by	NULL
using	NULL
human	NULL
IL-1B	NULL
cDNA	NULL
and	NULL
the	NULL
synthetic	NULL
oligonucleotide	NULL
sequence	NULL
of	NULL
IL-1B	NULL
as	NULL
probes	NULL
.	NULL

Eight	NULL
positive	NULL
clones	NULL
were	NULL
picked	NULL
up	NULL
,	NULL
and	NULL
one	NULL
of	NULL
the	NULL
eight	NULL
was	NULL
used	NULL
for	NULL
subcloning	NULL
.	NULL

An	NULL
IL-1B	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-1130	NULL
to	NULL
+15	NULL
(	NULL
-1130/	NULL
+15	NULL
fragment	NULL
)	NULL
was	NULL
cut	NULL
out	NULL
with	NULL
restriction	NULL
enzymes	NULL
Xbal	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Brou	NULL
.	NULL

and	NULL
Taql	NULL
,	NULL
and	NULL
subcloned	NULL
into	NULL
a	NULL
polylinker	NULL
site	NULL
in	NULL
front	NULL
of	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
structural	NULL
gene	NULL
on	NULL
the	NULL
plasmid	NULL
vector	NULL
pTK	NULL
(	NULL
-	NULL
)	NULL
.CAT	NULL
(	NULL
from	NULL
Herbert	NULL
Samuels	NULL
,	NULL
New	NULL
York	NULL
University	NULL
Medical	NULL
Center	NULL
)	NULL
.	NULL

A	NULL
series	NULL
of	NULL
deletion	NULL
mutant	NULL
fragments	NULL
were	NULL
created	NULL
by	NULL
restriction	NULL
enzyme	NULL
cutting	NULL
from	NULL
the	NULL
5	NULL
end	NULL
,	NULL
namely	NULL
,	NULL
Sau3	NULL
(	NULL
-680	NULL
)	NULL
,	NULL
Styl	NULL
(	NULL
-490	NULL
)	NULL
,	NULL
Dral	NULL
(	NULL
-313	NULL
)	NULL
,	NULL
HindIII	NULL
(	NULL
-131	NULL
)	NULL
,	NULL
and	NULL
Ddel	NULL
(	NULL
-69	NULL
)	NULL
fragments	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
human	NULL
suspension	NULL
cultures	NULL
and	NULL
assay	NULL
of	NULL
CAT	NULL
activity	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
serially	NULL
constructed	NULL
plasmids	NULL
by	NULL
the	NULL
DEAE-dextran	NULL
method	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
STBS	NULL
solution	NULL
(	NULL
25	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.4	NULL
}	NULL
,	NULL
137	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
KCl	NULL
,	NULL
0.6	NULL
mM	NULL
Na	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
0.7	NULL
mM	NULL
CaCl	NULL
,	NULL
,	NULL
0.5	NULL
mM	NULL
MgC1	NULL
;	NULL
)	NULL
and	NULL
were	NULL
transfected	NULL
with	NULL
10	NULL
ug	NULL
of	NULL
CsCl	NULL
,	NULL
-purified	NULL
plasmids	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
STBS	NULL
solution	NULL
containing	NULL
500	NULL
pg	NULL
of	NULL
DEAE-dextran	NULL
per	NULL
ml	NULL
at	NULL
37°C	NULL
for	NULL
90	NULL
min	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
then	NULL
washed	NULL
with	NULL
STBS	NULL
solution	NULL
and	NULL
incubated	NULL
in	NULL
complete	NULL
medium	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
inducing	NULL
agents	NULL
.	NULL

The	NULL
transfected	NULL
cells	NULL
were	NULL
lysed	NULL
by	NULL
three	NULL
cycles	NULL
of	NULL
freeze-thawing	NULL
,	NULL
and	NULL
equal	NULL
amounts	NULL
of	NULL
protein	NULL
from	NULL
different	NULL
cell	NULL
extracts	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
(	NULL
21	NULL
)	NULL
.	NULL

The	NULL
protein	NULL
concentration	NULL
was	NULL
determined	NULL
with	NULL
Bio-Rad	NULL
reagents	NULL
.	NULL

For	NULL
the	NULL
CAT	NULL
assay	NULL
,	NULL
100	NULL
ug	NULL
of	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
0.1	NULL
wCi	NULL
of	NULL
[	NULL
'*C	NULL
)	NULL
chloramphenicol-250	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
-360	NULL
ug	NULL
of	NULL
acetyl	NULL
coenzyme	NULL
A	NULL
per	NULL
ml	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
170	NULL
pl	NULL
at	NULL
37°C	NULL
for	NULL
5	NULL
h.	NULL
The	NULL
reactions	NULL
were	NULL
stopped	NULL
by	NULL
addition	NULL
of	NULL
0.5	NULL
ml	NULL
of	NULL
cold	NULL
ethyl	NULL
acetate	NULL
.	NULL

After	NULL
extraction	NULL
with	NULL
ethyl	NULL
acetate	NULL
,	NULL
the	NULL
upper	NULL
layer	NULL
was	NULL
saved	NULL
,	NULL
dried	NULL
,	NULL
and	NULL
spotted	NULL
onto	NULL
a	NULL
thin-layer	NULL
chromatography	NULL
plate	NULL
.	NULL

After	NULL
being	NULL
developed	NULL
in	NULL
organic	NULL
solution	NULL
(	NULL
95	NULL
%	NULL
chloroform	NULL
and	NULL
5	NULL
%	NULL
methanol	NULL
)	NULL
,	NULL
the	NULL
plate	NULL
was	NULL
air-dried	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
.	NULL

Preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
and	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
THP	NULL
-1	NULL
cells	NULL
by	NULL
using	NULL
the	NULL
method	NULL
first	NULL
described	NULL
by	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
16	NULL
)	NULL
.	NULL

Cultures	NULL
(	NULL
approximately	NULL
5	NULL
x	NULL
10°	NULL
cells	NULL
)	NULL
were	NULL
lysed	NULL
by	NULL
homogenization	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
[	NULL
N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic	NULL
acid	NULL
,	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
10	NULL
mM	NULL
KCI	NULL
,	NULL
0.5	NULL
mM	NULL
dithiothreitol	NULL
[	NULL
DTT	NULL
]	NULL
,	NULL
0.5	NULL
mM	NULL
phenylmethylIsul-fonyl	NULL
fluoride	NULL
[	NULL
PMSF	NULL
]	NULL
)	NULL
and	NULL
centrifuged	NULL
at	NULL
1,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
washed	NULL
with	NULL
buffer	NULL
A	NULL
once	NULL
.	NULL

The	NULL
nuclear	NULL
proteins	NULL
were	NULL
extracted	NULL
in	NULL
buffer	NULL
C	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
25	NULL
%	NULL
glycerol	NULL
,	NULL
0.42	NULL
M	NULL
NaCl	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
30	NULL
min	NULL
with	NULL
shaking	NULL
.	NULL

The	NULL
extracted	NULL
nuclear	NULL
proteins	NULL
were	NULL
dialyzed	NULL
against	NULL
buffer	NULL
D	NULL
(	NULL
20	NULL
mM	NULL
HEPES	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
,	NULL
20	NULL
%	NULL
glycerol	NULL
,	NULL
0.1	NULL
M	NULL
KCl	NULL
,	NULL
0.2	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
mM	NULL
DTT	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
)	NULL
for	NULL
5	NULL
h	NULL
and	NULL
were	NULL
frozen	NULL
in	NULL
liquid	NULL
nitrogen	NULL
in	NULL
aliquots	NULL
.	NULL

The	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
was	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
by	NULL
Sen	NULL
and	NULL
Baltimore	NULL
(	NULL
37	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
probes	NULL
were	NULL
end-labeled	NULL
by	NULL
using	NULL
polynucleotide	NULL
kinase	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
100	NULL
Ci	NULL
of	NULL
[	NULL
y-*°PJATP	NULL
.	NULL

Probes	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
nuclear	NULL
extracts	NULL
under	NULL
binding	NULL
conditions	NULL
[	NULL
of	NULL
10	NULL
mM	NULL
Tris	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.1	NULL
mM	NULL
DTT	NULL
,	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
and	NULL
10	NULL
%	NULL
glycerol	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
15	NULL
min	NULL
,	NULL
and	NULL
then	NULL
the	NULL
probes	NULL
were	NULL
electrophoresed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
analyzed	NULL
by	NULL
autoradiography	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
genes	NULL
after	NULL
stimulation	NULL
with	NULL
M.	NULL
tuberculosis	NULL
.	NULL

Exaggerated	NULL
quantities	NULL
of	NULL
the	NULL
cytokines	NULL
IL-18	NULL
and	NULL
TNF-a	NULL
are	NULL
released	NULL
after	NULL
stimulation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
in	NULL
vitro	NULL
with	NULL
components	NULL
purified	NULL
from	NULL
M.	NULL
tuberculosis	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
PBMs	NULL
stimulated	NULL
for	NULL
5	NULL
h	NULL
with	NULL
LAM	NULL
,	NULL
HSP-65kD	NULL
,	NULL
or	NULL
culture	NULL
filtrate	NULL
upregulate	NULL
Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
2	NULL
3	NULL
4	NULL
5	NULL
1.6kb	NULL
-	NULL
»	NULL
17+	NULL
_	NULL
``	NULL
a	NULL
WHK	NULL
a	NULL
IL-1	NULL
TNFa	NULL
C.	NULL
1°	NULL
2	NULL
8	NULL
4	NULL
``	NULL
5	NULL
io	NULL
~	NULL
>	NULL
#	NULL
%	NULL
&	NULL
&	NULL
8	NULL
pHe7	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
levels	NULL
in	NULL
PBMs	NULL
after	NULL
stimulation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Analysis	NULL
of	NULL
steady-state	NULL
IL-1B	NULL
mRNA	NULL
levels	NULL
.	NULL

Human	NULL
PBMs	NULL
were	NULL
isolated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
and	NULL
were	NULL
stimulated	NULL
for	NULL
5	NULL
h	NULL
with	NULL
the	NULL
following	NULL
stimuli	NULL
(	NULL
by	NULL
lane	NULL
)	NULL
:	NULL
2	NULL
,	NULL
TNF-a	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
;	NULL
3	NULL
,	NULL
LAM	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
;	NULL
4	NULL
,	NULL
HSP-65kD	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
;	NULL
5	NULL
,	NULL
culture	NULL
filtrate	NULL
(	NULL
100	NULL
ng/ml	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
was	NULL
the	NULL
control	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TNF-a	NULL
mRNA	NULL
.	NULL

Lanes	NULL
are	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
.	NULL

(	NULL
C	NULL
)	NULL
pHe7	NULL
housekeeping	NULL
gene	NULL
in	NULL
mRNA	NULL
.	NULL

Lanes	NULL
are	NULL
as	NULL
in	NULL
panel	NULL
A.	NULL
IL-18	NULL
and	NULL
TNF-a	NULL
mRNA	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
Northern	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
and	NULL
B	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

Equal	NULL
amounts	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
placed	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
pHe7	NULL
housekeeping	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
LAM	NULL
and	NULL
HSP-65kD	NULL
were	NULL
similar	NULL
in	NULL
their	NULL
stimulation	NULL
of	NULL
IL-18	NULL
and	NULL
TNF-a	NULL
mRNA	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
the	NULL
culture	NULL
filtrate	NULL
from	NULL
the	NULL
Erdman	NULL
strain	NULL
of	NULL
M.	NULL
tuberculosis	NULL
was	NULL
less	NULL
potent	NULL
.	NULL

All	NULL
three	NULL
stimuli	NULL
were	NULL
evaluated	NULL
for	NULL
LPS	NULL
contamination	NULL
by	NULL
the	NULL
amebocyte	NULL
lysate	NULL
assay	NULL
and	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
<	NULL
5	NULL
pg/ug	NULL
of	NULL
test	NULL
reagent	NULL
in	NULL
the	NULL
several	NULL
lots	NULL
tested	NULL
.	NULL

Analysis	NULL
of	NULL
IL-1B	NULL
promoter	NULL
region	NULL
by	NULL
deletion	NULL
analysis	NULL
.	NULL

In	NULL
order	NULL
to	NULL
investigate	NULL
the	NULL
molecular	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
IL-1B	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
initiated	NULL
experiments	NULL
aimed	NULL
at	NULL
the	NULL
identification	NULL
of	NULL
DNA	NULL
sequences	NULL
responsible	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
.	NULL

A	NULL
1,145-bp	NULL
IL-1B	NULL
DNA	NULL
fragment	NULL
(	NULL
-1130/+15	NULL
)	NULL
was	NULL
isolated	NULL
from	NULL
a	NULL
human	NULL
genomic	NULL
library	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pTK	NULL
(	NULL
-	NULL
)	NULL
.CAT	NULL
plasmid	NULL
.	NULL

This	NULL
DNA	NULL
fragment	NULL
contains	NULL
several	NULL
sequences	NULL
resembling	NULL
known	NULL
regulatory	NULL
elements	NULL
,	NULL
as	NULL
schematically	NULL
illustrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

To	NULL
identify	NULL
cis-acting	NULL
elements	NULL
responsive	NULL
to	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
,	NULL
four	NULL
IL-1B	NULL
DNA	NULL
fragments	NULL
with	NULL
deletions	NULL
from	NULL
the	NULL
5°	NULL
end	NULL
were	NULL
fused	NULL
to	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
IL-1B	NULL
promoter	NULL
region	NULL
was	NULL
determined	NULL
by	NULL
measuring	NULL
CAT	NULL
activities	NULL
in	NULL
THP-1	NULL
cells	NULL
transfected	NULL
with	NULL
these	NULL
constructs	NULL
after	NULL
stimulation	NULL
with	NULL
the	NULL
different	NULL
reagents	NULL
.	NULL

Our	NULL
results	NULL
showed	NULL
that	NULL
CAT	NULL
activity	NULL
gradually	NULL
increased	NULL
as	NULL
deletion	NULL
advanced	NULL
from	NULL
positions	NULL
-1130	NULL
to	NULL
-313	NULL
and	NULL
to	NULL
-131	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

After	NULL
further	NULL
deletion	NULL
to	NULL
position	NULL
-69	NULL
,	NULL
which	NULL
resulted	NULL
in	NULL
the	NULL
removal	NULL
of	NULL
a	NULL
sequence	NULL
(	NULL
-90/-82	NULL
)	NULL
that	NULL
shared	NULL
high	NULL
homology	NULL
with	NULL
the	NULL
NF-IL6	NULL
binding	NULL
site	NULL
,	NULL
there	NULL
was	NULL
only	NULL
one-half	NULL
to	NULL
three-fourths	NULL
the	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
over	NULL
that	NULL
of	NULL
the	NULL
control	NULL
after	NULL
stimulation	NULL
.	NULL

The	NULL
data	NULL
suggest	NULL
that	NULL
major	NULL
positive	NULL
regulating	NULL
elements	NULL
on	NULL
the	NULL
IL-1B	NULL
gene	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
are	NULL
located	NULL
IL-18	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
NF-IL6	NULL
MOTIFS	NULL
3833	NULL
4	NULL
NF-kB	NULL
__	NULL
NF-IL-6	NULL
|	NULL
°9°	NULL
I	NULL
|	NULL
-1	NULL
I-h-H-t=	NULL
--	NULL
-s	NULL
lapa	NULL
_	NULL
|	NULL
SRE	NULL
TATA	NULL
~318	NULL
--	NULL
--	NULL
--	NULL
--	NULL
--	NULL
-	NULL
}	NULL
-	NULL
i415	NULL
131	NULL
--	NULL
--	NULL
f-+15	NULL
-69	NULL
--	NULL
-	NULL
+15	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Summary	NULL
of	NULL
deletion	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-1B	NULL
gene	NULL
.	NULL

Serial	NULL
deletion	NULL
mutants	NULL
of	NULL
the	NULL
IL-1B	NULL
DNA	NULL
(	NULL
-1130/+15	NULL
)	NULL
were	NULL
created	NULL
by	NULL
using	NULL
several	NULL
restriction	NULL
endonu-cleases	NULL
and	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
polylinker	NULL
sites	NULL
of	NULL
plasmid	NULL
pTK	NULL
(	NULL
-	NULL
)	NULL
.CAT	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Abbrevia-tions	NULL
:	NULL
SRE	NULL
,	NULL
serum	NULL
response	NULL
element	NULL
;	NULL
AP-1	NULL
,	NULL
activating	NULL
protein	NULL
1	NULL
;	NULL
NF-kB	NULL
,	NULL
binding	NULL
site	NULL
for	NULL
nuclear	NULL
binding	NULL
protein	NULL
«	NULL
B	NULL
;	NULL
NF-IL6	NULL
,	NULL
binding	NULL
sites	NULL
for	NULL
nuclear	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
IL-6	NULL
gene	NULL
;	NULL
OCTA	NULL
,	NULL
octamer	NULL
binding	NULL
site	NULL
.	NULL

p	NULL
}	NULL
-1130	NULL
1	NULL
between	NULL
positions	NULL
-131	NULL
and	NULL
+15	NULL
because	NULL
removal	NULL
of	NULL
the	NULL
fragment	NULL
(	NULL
-1130/-131	NULL
)	NULL
did	NULL
not	NULL
decrease	NULL
CAT	NULL
activity	NULL
.	NULL

CAT	NULL
activity	NULL
actually	NULL
increased	NULL
after	NULL
deletion	NULL
of	NULL
this	NULL
fragment	NULL
.	NULL

This	NULL
phenomenon	NULL
may	NULL
be	NULL
due	NULL
to	NULL
derepression	NULL
by	NULL
removal	NULL
of	NULL
some	NULL
negative	NULL
regulatory	NULL
element	NULL
(	NULL
s	NULL
)	NULL
within	NULL
this	NULL
DNA	NULL
fragment	NULL
(	NULL
-1130/-131	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
of	NULL
stimulated	NULL
versus	NULL
unstimulated	NULL
cells	NULL
after	NULL
deletion	NULL
from	NULL
positions	NULL
-131	NULL
to	NULL
-69	NULL
actually	NULL
was	NULL
smaller	NULL
,	NULL
strongly	NULL
suggesting	NULL
that	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
or	NULL
elements	NULL
existed	NULL
between	NULL
positions	NULL
-131	NULL
and	NULL
-69	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
the	NULL
84-bp	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-69	NULL
to	NULL
+15	NULL
still	NULL
showed	NULL
a	NULL
significant	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
after	NULL
stimulation	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
84-bp-long	NULL
DNA	NULL
sequence	NULL
also	NULL
contains	NULL
a	NULL
positive	NULL
regulatory	NULL
element	NULL
or	NULL
elements	NULL
in	NULL
response	NULL
to	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
.	NULL

LAM	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
have	NULL
common	NULL
positive	NULL
regulatory	NULL
elements	NULL
.	NULL

There	NULL
are	NULL
two	NULL
sequences	NULL
on	NULL
IL-1f	NULL
that	NULL
share	NULL
the	NULL
NF-IL-6	NULL
consensus	NULL
sequence	NULL
T	NULL
(	NULL
T/G	NULL
)	NULL
NNGNAA	NULL
(	NULL
T/G	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

They	NULL
are	NULL
5-TTGTGAAAT-3	NULL
'	NULL
(	NULL
-90/-82	NULL
)	NULL
and	NULL
5'-TTITTGAA	NULL
AG-3	NULL
'	NULL
(	NULL
-40/-32	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
two	NULL
sequences	NULL
are	NULL
the	NULL
positive	NULL
regulatory	NULL
element	NULL
(	NULL
s	NULL
)	NULL
,	NULL
we	NULL
performed	NULL
site-directed	NULL
mutagenesis	NULL
of	NULL
the	NULL
IL-1B	NULL
DNA	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

The	NULL
-1130/+15	NULL
-313/+15	NULL
~131/+15	NULL
69/+15	NULL
C	NULL
LAMLPS	NULL
TNFa	NULL
C	NULL
LAMLPSTNFa	NULL
«	NULL
C_	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
C	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
1	NULL
53	NULL
4.7	NULL
29	NULL
1	NULL
48	NULL
45	NULL
4.0	NULL
1	NULL
42	NULL
4.0	NULL
6.7	NULL
1	NULL
3.1	NULL
3.0	NULL
2.8	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Deletion	NULL
analysis	NULL
of	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
four	NULL
plasmid	NULL
constructs	NULL
of	NULL
the	NULL
IL-1B	NULL
promoter	NULL
region	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
numbers	NULL
on	NULL
the	NULL
top	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
LAM	NULL
(	NULL
500	NULL
ng/m	NULL
!	NULL

l	NULL
)	NULL
,	NULL
LPS	NULL
(	NULL
500	NULL
ng/mi	NULL
)	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
cytosolic	NULL
extracts	NULL
from	NULL
the	NULL
transfected	NULL
THP-1	NULL
cells	NULL
were	NULL
assayed	NULL
for	NULL
CAT	NULL
activity	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
over	NULL
control	NULL
(	NULL
C	NULL
)	NULL
activity	NULL
is	NULL
given	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

3834	NULL
ZHANG	NULL
AND	NULL
ROM	NULL
p	NULL
»	NULL
-1	NULL
-1	NULL
-1	NULL
-a-	NULL
—1314—X—	NULL
;	NULL
—F.15	NULL
—131—	NULL
{	NULL
—*—	NULL
;	NULL
—§-+15	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
NEAL6	NULL
-	NULL
TATA	NULL
NF-IL-6	NULL
-	NULL
TATA	NULL
C	NULL
_	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
NF-IL-6	NULL
-	NULL
TATA	NULL
C	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
C	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
&	NULL
e	NULL
G	NULL
e	NULL
€	NULL
%	NULL
#	NULL
b	NULL
#	NULL
#	NULL
ife	NULL
<	NULL
%	NULL
10	NULL
4.9	NULL
4140	NULL
4.0	NULL
1	NULL
52	NULL
54	NULL
5.9	NULL
1	NULL
11	NULL
1.0	NULL
08	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
IL-18	NULL
promoter	NULL
region	NULL
by	NULL
site-directed	NULL
mutagenesis	NULL
.	NULL

Three	NULL
plasmids	NULL
constructed	NULL
with	NULL
one	NULL
NF-IL6	NULL
mutation	NULL
or	NULL
double	NULL
NF-IL6	NULL
site	NULL
mutations	NULL
were	NULL
tested	NULL
by	NULL
transient	NULL
transfection	NULL
and	NULL
CAT	NULL
assays	NULL
in	NULL
THP-1	NULL
cells	NULL
as	NULL
shown	NULL
on	NULL
the	NULL
top	NULL
.	NULL

The	NULL
boxes	NULL
labeled	NULL
X	NULL
represent	NULL
the	NULL
mutated	NULL
NF-IL6	NULL
motifs	NULL
,	NULL
and	NULL
the	NULL
fold	NULL
increase	NULL
over	NULL
control	NULL
(	NULL
C	NULL
)	NULL
activity	NULL
is	NULL
given	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

mutations	NULL
were	NULL
made	NULL
as	NULL
follows	NULL
:	NULL
(	NULL
i	NULL
)	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
-90/-82	NULL
)	NULL
was	NULL
mutated	NULL
to	NULL
5'-CCGTAAAAG-3	NULL
'	NULL
;	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
second	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
-40/-32	NULL
)	NULL
was	NULL
mutated	NULL
to	NULL
5'-CCT	NULL
TAAAAG-3	NULL
'	NULL
.	NULL

Three	NULL
kinds	NULL
of	NULL
mutations	NULL
were	NULL
carried	NULL
out	NULL
by	NULL
mutating	NULL
either	NULL
one	NULL
of	NULL
the	NULL
NF-IL6-like	NULL
sites	NULL
and	NULL
leaving	NULL
the	NULL
other	NULL
one	NULL
intact	NULL
and	NULL
mutating	NULL
both	NULL
NF-IL6-like	NULL
sites	NULL
.	NULL

The	NULL
mutants	NULL
were	NULL
sequenced	NULL
to	NULL
confirm	NULL
the	NULL
correct	NULL
mutation	NULL
.	NULL

Induction	NULL
of	NULL
CAT	NULL
activity	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
was	NULL
striking	NULL
,	NULL
with	NULL
mutation	NULL
of	NULL
the	NULL
5°	NULL
NF-IL6	NULL
site	NULL
leaving	NULL
the	NULL
3	NULL
'	NULL
site	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
left	NULL
panel	NULL
)	NULL
or	NULL
mutation	NULL
of	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
site	NULL
leaving	NULL
the	NULL
5°	NULL
NF-IL6	NULL
site	NULL
intact	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
middle	NULL
panel	NULL
)	NULL
.	NULL

After	NULL
mutation	NULL
of	NULL
both	NULL
NF-IL6	NULL
sites	NULL
,	NULL
inducibility	NULL
of	NULL
the	NULL
IL-1	NULL
promoter	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
was	NULL
abolished	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
inducibility	NULL
of	NULL
CAT	NULL
activity	NULL
on	NULL
the	NULL
wild-type	NULL
-131/+15	NULL
DNA	NULL
fragment	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

These	NULL
experiments	NULL
suggested	NULL
that	NULL
the	NULL
two	NULL
NF-IL6	NULL
sites	NULL
on	NULL
the	NULL
IL-1B	NULL
gene	NULL
functioned	NULL
as	NULL
positive	NULL
regulatory	NULL
sequences	NULL
in	NULL
response	NULL
to	NULL
the	NULL
induction	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
.	NULL

Each	NULL
of	NULL
the	NULL
NF-IL6	NULL
sites	NULL
functioned	NULL
independently	NULL
of	NULL
the	NULL
other	NULL
because	NULL
a	NULL
single	NULL
mutation	NULL
did	NULL
not	NULL
affect	NULL
CAT	NULL
activity	NULL
.	NULL

NF-IL6	NULL
motifs	NULL
on	NULL
the	NULL
IL-1B	NULL
gene	NULL
act	NULL
in	NULL
an	NULL
orientation-independent	NULL
manner	NULL
.	NULL

Experiments	NULL
were	NULL
conducted	NULL
with	NULL
the	NULL
DNA	NULL
fragments	NULL
containing	NULL
the	NULL
5°	NULL
NF-IL6	NULL
or	NULL
3	NULL
'	NULL
NF-IL6	NULL
motifs	NULL
subcloned	NULL
into	NULL
the	NULL
polylinker	NULL
sites	NULL
of	NULL
the	NULL
plasmid	NULL
pTK.CAT	NULL
in	NULL
either	NULL
orientation	NULL
.	NULL

THP-1	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
these	NULL
constructs	NULL
and	NULL
were	NULL
stimulated	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Stimulation	NULL
of	NULL
the	NULL
-131/-69	NULL
fragment	NULL
(	NULL
containing	NULL
the	NULL
-90/-82	NULL
NF-IL6	NULL
site	NULL
)	NULL
with	NULL
any	NULL
of	NULL
the	NULL
stimuli	NULL
revealed	NULL
enhanced	NULL
CAT	NULL
activity	NULL
with	NULL
either	NULL
orientation	NULL
of	NULL
the	NULL
DNA	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
left	NULL
and	NULL
middle	NULL
panels	NULL
)	NULL
.	NULL

There	NULL
was	NULL
no	NULL
CAT	NULL
activity	NULL
induced	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
pTK	NULL
(	NULL
-	NULL
)	NULL
.CAT	NULL
plasmid	NULL
vector	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
a	NULL
-68/-31	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
site	NULL
(	NULL
-40/-32	NULL
)	NULL
.	NULL

Enhanced	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
after	NULL
any	NULL
of	NULL
the	NULL
stimuli	NULL
with	NULL
the	NULL
DNA	NULL
fragment	NULL
in	NULL
either	NULL
orientation	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
left	NULL
and	NULL
middle	NULL
panels	NULL
)	NULL
,	NULL
and	NULL
no	NULL
CAT	NULL
activity	NULL
was	NULL
induced	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
pTK.CAT	NULL
plasmid	NULL
vector	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

LAM	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
TNF-a	NULL
enhance	NULL
interaction	NULL
between	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
and	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
interacts	NULL
specifically	NULL
with	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

Bror	NULL
.	NULL

3	NULL
-+	NULL
»	NULL
5	NULL
-69	NULL
--	NULL
NF-IL-6	NULL
-131	NULL
5°	NULL
-	NULL
»	NULL
3	NULL
``	NULL
131	NULL
-	NULL
[	NULL
NEICS	NULL
]	NULL
--	NULL
so	NULL
C_	NULL
LAMLPS	NULL
TNFa	NULL
pTK.CAT	NULL
C	NULL
_	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
C	NULL
__	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
1	NULL
6.5	NULL
6.4	NULL
6.0	NULL
1	NULL
4.8	NULL
4.3	NULL
2.9	NULL
1	NULL
0.9	NULL
0.7	NULL
0.7	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

The	NULL
cis-acting	NULL
element	NULL
(	NULL
-90/-82	NULL
)	NULL
that	NULL
mediates	NULL
induction	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
and	NULL
TNF-a	NULL
functions	NULL
in	NULL
front	NULL
of	NULL
a	NULL
heterologous	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
an	NULL
orientation-independent	NULL
manner	NULL
.	NULL

The	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-131	NULL
to	NULL
-69	NULL
which	NULL
contains	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
-90/-82	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
polylinker	NULL
sites	NULL
of	NULL
pTK.CAT	NULL
in	NULL
either	NULL
orientation	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
pTK.CAT	NULL
vector	NULL
was	NULL
included	NULL
.	NULL

The	NULL
fold	NULL
increase	NULL
over	NULL
unstimulated	NULL
cells	NULL
is	NULL
given	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

nuclear	NULL
proteins	NULL
,	NULL
THP-1	NULL
cultures	NULL
were	NULL
treated	NULL
with	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
to	NULL
NF-IL6	NULL
sequences	NULL
was	NULL
tested	NULL
by	NULL
the	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Nuclear	NULL
proteins	NULL
isolated	NULL
from	NULL
stimulated	NULL
THP-1	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
end-labeled	NULL
synthetic	NULL
double-stranded	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
NF-IL6	NULL
probes	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
specific	NULL
or	NULL
nonspecific	NULL
competitors	NULL
.	NULL

After	NULL
treatment	NULL
with	NULL
C_	NULL
_	NULL
>	NULL
4	NULL
2	NULL
-~	NULL
A	NULL
-68	NULL
-	NULL
[	NULL
NFE-IL-6	NULL
|-	NULL
-31	NULL
-31	NULL
-	NULL
[	NULL
NE-IL-6	NULL
}	NULL
--	NULL
68	NULL
pTK.CAT	NULL
C	NULL
LAM	NULL
LPS	NULL
TNF	NULL
«	NULL
C	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
C_	NULL
LAM	NULL
LPS	NULL
TNFa	NULL
a	NULL
1	NULL
6.9	NULL
6.3	NULL
7.0	NULL
1°	NULL
4m	NULL
se	NULL
30	NULL
1	NULL
``	NULL
0.9	NULL
1.1	NULL
~0.7	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

The	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
-40/-32	NULL
)	NULL
functions	NULL
in	NULL
front	NULL
of	NULL
a	NULL
heterologous	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
in	NULL
an	NULL
orientation-independent	NULL
manner	NULL
.	NULL

The	NULL
DNA	NULL
fragment	NULL
from	NULL
positions	NULL
-68	NULL
to	NULL
-31	NULL
which	NULL
contains	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
(	NULL
-40/-32	NULL
)	NULL
was	NULL
subcloned	NULL
into	NULL
the	NULL
polylinker	NULL
sites	NULL
of	NULL
pTK.CAT	NULL
in	NULL
either	NULL
orientation	NULL
.	NULL

The	NULL
pTK.CAT	NULL
vector	NULL
is	NULL
a	NULL
control	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
the	NULL
fold	NULL
increase	NULL
over	NULL
activity	NULL
of	NULL
unstimulated	NULL
cells	NULL
is	NULL
given	NULL
below	NULL
each	NULL
lane	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
A.	NULL
LAM	NULL
B	NULL
:	NULL
LPS	NULL
C.	NULL
TNF	NULL
«	NULL
14	NULL
02	NULL
C3	NULL
~4	NULL
5:06	NULL
©7-	NULL
B	NULL
9	NULL
10	NULL
11	NULL
12	NULL
bud	NULL
but	NULL
be	NULL
b	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
5	NULL
NF-IL6	NULL
sequence	NULL
as	NULL
analyzed	NULL
by	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Stimulated	NULL
THP-1	NULL
cell	NULL
nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
*P-	NULL
end-labeled	NULL
synthetic	NULL
5°	NULL
NF-IL6	NULL
probe	NULL
(	NULL
10,000	NULL
cpm	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
competitors	NULL
under	NULL
the	NULL
binding	NULL
conditions	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Lanes	NULL
:	NULL
1	NULL
,	NULL
5	NULL
,	NULL
and	NULL
9	NULL
,	NULL
unstimulated	NULL
nuclear	NULL
extracts	NULL
;	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
,	NULL
LAM-	NULL
,	NULL
LPS-	NULL
,	NULL
and	NULL
TNF-a-stimulated	NULL
nuclear	NULL
extracts	NULL
,	NULL
respectively	NULL
;	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
,	NULL
LAM-	NULL
,	NULL
LPS-	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
-stimulated	NULL
nuclear	NULL
extracts	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
synthetic	NULL
mutant	NULL
NF-IL6	NULL
se-quence	NULL
;	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
,	NULL
LAM-	NULL
,	NULL
LPS-	NULL
,	NULL
and	NULL
TNF-o-stimulated	NULL
nuclear	NULL
extracts	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
synthetic	NULL
wild-type	NULL
NF-IL6é	NULL
DNA	NULL
.	NULL

LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
«	NULL
,	NULL
a	NULL
dramatically	NULL
enhanced	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
5°	NULL
NF-IL6	NULL
site	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
6	NULL
,	NULL
and	NULL
10	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
the	NULL
binding	NULL
was	NULL
specific	NULL
,	NULL
competition	NULL
experiments	NULL
were	NULL
carried	NULL
out	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
wild-type	NULL
or	NULL
mutated	NULL
NF-IL6	NULL
probe	NULL
.	NULL

The	NULL
protein-DNA	NULL
interaction	NULL
was	NULL
still	NULL
present	NULL
after	NULL
competition	NULL
experiments	NULL
with	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
cold	NULL
mutated	NULL
NF-IL6	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
7	NULL
,	NULL
and	NULL
11	NULL
)	NULL
.	NULL

However	NULL
,	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
NF-IL6	NULL
site	NULL
was	NULL
abolished	NULL
by	NULL
competition	NULL
performed	NULL
with	NULL
100-fold	NULL
excess	NULL
cold	NULL
wild-type	NULL
NF-IL6	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
lanes	NULL
4	NULL
,	NULL
8	NULL
,	NULL
and	NULL
12	NULL
)	NULL
after	NULL
stimulation	NULL
by	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
,	NULL
respectively	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
by	NULL
using	NULL
end-labeled	NULL
3	NULL
'	NULL
NF-IL6	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
,	NULL
same	NULL
lanes	NULL
as	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

These	NULL
data	NULL
strongly	NULL
suggested	NULL
that	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-a	NULL
activated	NULL
the	NULL
IL-1B	NULL
gene	NULL
by	NULL
enhancing	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
and	NULL
its	NULL
binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
.	NULL

DISCUSSION	NULL
IL-1B	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
cytokine	NULL
in	NULL
the	NULL
host	NULL
response	NULL
to	NULL
M.	NULL
tuberculosis	NULL
in	NULL
that	NULL
large	NULL
quantities	NULL
can	NULL
be	NULL
released	NULL
in	NULL
vitro	NULL
after	NULL
stimulation	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
(	NULL
5	NULL
,	NULL
13	NULL
,	NULL
41	NULL
)	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
LAM	NULL
can	NULL
increase	NULL
the	NULL
IL-1B	NULL
and	NULL
TNF-	NULL
«	NULL
mRNA	NULL
level	NULL
in	NULL
PBMs	NULL
,	NULL
and	NULL
this	NULL
increase	NULL
was	NULL
greater	NULL
than	NULL
the	NULL
increase	NULL
elicited	NULL
by	NULL
a	NULL
LAM-free	NULL
culture	NULL
filtrate	NULL
from	NULL
the	NULL
Erdman	NULL
strain	NULL
.	NULL

The	NULL
HSP-65kD	NULL
IL-18	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
NF-IL6	NULL
MOTIFS	NULL
3835	NULL
A.	NULL
LAM	NULL
B.	NULL
LPS	NULL
C.	NULL
TNFa	NULL
10203	NULL
4	NULL
5	NULL
6	NULL
<	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
~~~	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
binding	NULL
of	NULL
nuclear	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
to	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
sequence	NULL
as	NULL
analyzed	NULL
by	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

Lanes	NULL
are	NULL
identical	NULL
to	NULL
those	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
with	NULL
the	NULL
3	NULL
'	NULL
NF-IL6	NULL
sequence	NULL
used	NULL
as	NULL
an	NULL
end-labeled	NULL
probe	NULL
.	NULL

protein	NULL
was	NULL
equipotent	NULL
compared	NULL
with	NULL
LAM	NULL
in	NULL
stimulating	NULL
IL-18	NULL
and	NULL
TNF-a	NULL
gene	NULL
expression	NULL
and	NULL
is	NULL
a	NULL
cytosolic	NULL
protein	NULL
important	NULL
for	NULL
protein	NULL
assembly	NULL
,	NULL
folding	NULL
,	NULL
and	NULL
transport	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
LAM	NULL
was	NULL
the	NULL
most	NULL
potent	NULL
stimulus	NULL
of	NULL
IL-1B	NULL
mRNA	NULL
,	NULL
followed	NULL
by	NULL
HSP-65kD	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
the	NULL
culture	NULL
filtrate	NULL
.	NULL

Because	NULL
LAM	NULL
also	NULL
stimulates	NULL
TNF-	NULL
«	NULL
protein	NULL
and	NULL
mRNA	NULL
,	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
could	NULL
amplify	NULL
the	NULL
stimulus	NULL
for	NULL
IL-18	NULL
.	NULL

We	NULL
concentrated	NULL
on	NULL
investigating	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
IL-1B	NULL
gene	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
mycobacterial	NULL
cell	NULL
wall	NULL
component	NULL
LAM	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

By	NULL
comparing	NULL
the	NULL
action	NULL
of	NULL
LAM	NULL
to	NULL
that	NULL
of	NULL
LPS	NULL
,	NULL
we	NULL
showed	NULL
that	NULL
both	NULL
LAM	NULL
and	NULL
LPS	NULL
activate	NULL
the	NULL
IL-1B	NULL
gene	NULL
through	NULL
NF-IL6	NULL
binding	NULL
sequences	NULL
that	NULL
function	NULL
as	NULL
positive	NULL
regulatory	NULL
elements	NULL
.	NULL

TNF-a	NULL
,	NULL
a	NULL
well-known	NULL
activator	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
,	NULL
shared	NULL
a	NULL
similar	NULL
mechanism	NULL
with	NULL
LAM	NULL
or	NULL
LPS	NULL
in	NULL
IL-1B	NULL
gene	NULL
activation	NULL
in	NULL
human	NULL
myelomonocytic	NULL
THP-1	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
two	NULL
NF-IL6	NULL
sites	NULL
functioned	NULL
independently	NULL
in	NULL
response	NULL
to	NULL
LAM	NULL
,	NULL
LPS	NULL
,	NULL
or	NULL
TNF-	NULL
«	NULL
stimulation	NULL
because	NULL
mutation	NULL
of	NULL
either	NULL
of	NULL
them	NULL
did	NULL
not	NULL
interfere	NULL
with	NULL
the	NULL
function	NULL
of	NULL
the	NULL
other	NULL
.	NULL

An	NULL
NF-KB	NULL
site	NULL
located	NULL
at	NULL
fragment	NULL
-295/-286	NULL
can	NULL
be	NULL
activated	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
,	NULL
including	NULL
LPS	NULL
,	NULL
TNF-	NULL
«	NULL
,	NULL
and	NULL
IL-1	NULL
,	NULL
and	NULL
very	NULL
likely	NULL
LAM	NULL
,	NULL
because	NULL
LAM	NULL
activated	NULL
NF-	NULL
«	NULL
B	NULL
independently	NULL
on	NULL
the	NULL
IL-6	NULL
gene	NULL
(	NULL
44	NULL
)	NULL
.	NULL

LAM	NULL
or	NULL
LPS	NULL
induced	NULL
nuclear	NULL
proteins	NULL
that	NULL
bound	NULL
to	NULL
the	NULL
NF-IL6	NULL
wild-type	NULL
target	NULL
sequence	NULL
specifically	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
the	NULL
DNA	NULL
mobility	NULL
shift	NULL
assay	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
binding	NULL
of	NULL
the	NULL
LAM-	NULL
,	NULL
LPS-	NULL
,	NULL
or	NULL
TNF-a	NULL
«	NULL
-induced	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
NF-IL6	NULL
sites	NULL
contributed	NULL
to	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
IL-1B	NULL
gene	NULL
.	NULL

In	NULL
both	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
5'-	NULL
and	NULL
3'-end-labeled	NULL
NF-IL6	NULL
probes	NULL
,	NULL
the	NULL
stimulated	NULL
nuclear	NULL
proteins	NULL
were	NULL
shown	NULL
to	NULL
compete	NULL
with	NULL
wild-type	NULL
NF-IL6	NULL
,	NULL
and	NULL
the	NULL
TNF-a	NULL
«	NULL
-stimulated	NULL
nuclear	NULL
proteins	NULL
acted	NULL
similarly	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

This	NULL
report	NULL
also	NULL
demonstrates	NULL
that	NULL
LPS	NULL
from	NULL
gram-negative	NULL
bacteria	NULL
and	NULL
LAM	NULL
from	NULL
mycobacteria	NULL
function	NULL
through	NULL
similar	NULL
mechanisms	NULL
:	NULL
they	NULL
both	NULL
activate	NULL
NF-IL6	NULL
elements	NULL
on	NULL
the	NULL
IL-1B	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
NF-IL6	NULL
sequence	NULL
may	NULL
be	NULL
an	NULL
important	NULL
mycobacterial	NULL
or	NULL
bacterial	NULL
response	NULL
element	NULL
and	NULL
may	NULL
be	NULL
relevant	NULL
to	NULL
other	NULL
host	NULL
cytokines	NULL
(	NULL
1	NULL
,	NULL
23	NULL
)	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
LAM	NULL
activates	NULL
NF-IL6	NULL
sites	NULL
on	NULL
the	NULL
IL-6	NULL
gene	NULL
and	NULL
enhances	NULL
interactions	NULL
between	NULL
nuclear	NULL
proteins	NULL
and	NULL
the	NULL
NF-IL6	NULL
element	NULL
(	NULL
44	NULL
)	NULL
.	NULL

The	NULL
IL-18	NULL
gene	NULL
spans	NULL
a	NULL
region	NULL
of	NULL
7.5	NULL
kb	NULL
with	NULL
a	NULL
coding	NULL
region	NULL
divided	NULL
into	NULL
seven	NULL
exons	NULL
(	NULL
4	NULL
,	NULL
7	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Although	NULL
there	NULL
are	NULL
3836	NULL
ZHANG	NULL
AND	NULL
ROM	NULL
two	NULL
forms	NULL
of	NULL
IL-1	NULL
(	NULL
IL-l	NULL
«	NULL
and	NULL
IL-1B	NULL
)	NULL
encoded	NULL
by	NULL
two	NULL
separate	NULL
genes	NULL
with	NULL
only	NULL
26	NULL
%	NULL
similarity	NULL
in	NULL
their	NULL
amino	NULL
acid	NULL
sequences	NULL
and	NULL
45	NULL
%	NULL
similarity	NULL
in	NULL
their	NULL
nucleotide	NULL
sequences	NULL
,	NULL
they	NULL
bind	NULL
to	NULL
the	NULL
same	NULL
cell	NULL
surface	NULL
receptors	NULL
and	NULL
have	NULL
overlapping	NULL
biological	NULL
activities	NULL
(	NULL
1	NULL
,	NULL
4	NULL
,	NULL
7	NULL
,	NULL
14	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-l	NULL
«	NULL
has	NULL
two	NULL
NF-IL6	NULL
motifs	NULL
as	NULL
well	NULL
(	NULL
located	NULL
at	NULL
-199/191	NULL
and	NULL
-147/-139	NULL
)	NULL
and	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
-749/-740	NULL
)	NULL
site	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Pro-IL-1B	NULL
is	NULL
an	NULL
inactive	NULL
31-kDa	NULL
precursor	NULL
that	NULL
is	NULL
cleaved	NULL
by	NULL
IL-1B-converting	NULL
enzyme	NULL
between	NULL
Asp-116	NULL
and	NULL
Ala-117	NULL
,	NULL
releasing	NULL
the	NULL
153	NULL
COOH-terminal	NULL
amino	NULL
acids	NULL
that	NULL
constitute	NULL
the	NULL
mature	NULL
cytokine	NULL
(	NULL
4	NULL
,	NULL
9	NULL
,	NULL
31	NULL
)	NULL
.	NULL

Previous	NULL
investigators	NULL
have	NULL
reported	NULL
that	NULL
LPS	NULL
and	NULL
the	NULL
immediate-early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
(	NULL
CMV	NULL
IE	NULL
)	NULL
activated	NULL
promoter/enhancer	NULL
elements	NULL
on	NULL
the	NULL
5'-flanking	NULL
region	NULL
of	NULL
IL-1B	NULL
and	NULL
that	NULL
progressive	NULL
deletions	NULL
of	NULL
a	NULL
-1,097/	NULL
+14	NULL
sequence	NULL
localized	NULL
CMV	NULL
IE-responsive	NULL
elements	NULL
to	NULL
a	NULL
-131/+14	NULL
DNA	NULL
fragment	NULL
similar	NULL
to	NULL
the	NULL
one	NULL
we	NULL
isolated	NULL
(	NULL
15	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Crump	NULL
and	NULL
colleagues	NULL
described	NULL
a	NULL
15-fold	NULL
increase	NULL
in	NULL
CAT	NULL
activity	NULL
with	NULL
this	NULL
fragment	NULL
after	NULL
cotransfection	NULL
in	NULL
THP-1	NULL
cells	NULL
with	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
CMV	NULL
IE1	NULL
gene	NULL
(	NULL
15	NULL
)	NULL
.	NULL

In	NULL
this	NULL
regard	NULL
,	NULL
the	NULL
sequence	NULL
between	NULL
positions	NULL
-131	NULL
and	NULL
+15	NULL
is	NULL
an	NULL
important	NULL
positive	NULL
regulatory	NULL
element	NULL
on	NULL
the	NULL
IL-18B	NULL
gene	NULL
and	NULL
the	NULL
two	NULL
NF-IL6	NULL
motifs	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
promoter	NULL
activity	NULL
within	NULL
this	NULL
region	NULL
.	NULL

IL-1B	NULL
mRNA	NULL
in	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
-infected	NULL
mononuclear	NULL
phagocytes	NULL
increases	NULL
8-	NULL
to	NULL
15-fold	NULL
after	NULL
LPS	NULL
stimulation	NULL
in	NULL
comparison	NULL
with	NULL
non-HIV-l-infected	NULL
cells	NULL
that	NULL
were	NULL
similarly	NULL
stimulated	NULL
,	NULL
suggesting	NULL
synergism	NULL
in	NULL
transcriptional	NULL
activation	NULL
by	NULL
the	NULL
two	NULL
stimuli	NULL
(	NULL
42	NULL
)	NULL
.	NULL

HIV-1	NULL
tat	NULL
,	NULL
a	NULL
major	NULL
regulatory	NULL
protein	NULL
of	NULL
HIV-1	NULL
,	NULL
may	NULL
be	NULL
the	NULL
mediator	NULL
of	NULL
these	NULL
effects	NULL
.	NULL

The	NULL
NF	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
has	NULL
been	NULL
cloned	NULL
,	NULL
and	NULL
the	NULL
full-length	NULL
cDNA	NULL
encodes	NULL
a	NULL
345-amino-acid	NULL
protein	NULL
whose	NULL
C-terminal	NULL
portion	NULL
reveals	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
homology	NULL
to	NULL
the	NULL
C/EBP	NULL
family	NULL
of	NULL
liver-specific	NULL
transcriptional	NULL
factors	NULL
(	NULL
2	NULL
,	NULL
3	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
NF-IL6	NULL
binds	NULL
to	NULL
transcriptional	NULL
regulatory	NULL
regions	NULL
in	NULL
TNF-	NULL
«	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
NF-IL6	NULL
in	NULL
inflammation	NULL
and	NULL
the	NULL
acute	NULL
phase	NULL
response	NULL
.	NULL

Under	NULL
Northern	NULL
blot	NULL
analysis	NULL
,	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
,	NULL
especially	NULL
lung	NULL
,	NULL
expressed	NULL
NF-IL6	NULL
mRNA	NULL
after	NULL
LPS	NULL
stimulation	NULL
,	NULL
and	NULL
this	NULL
pattern	NULL
correlated	NULL
with	NULL
IL-6	NULL
induction	NULL
.	NULL

The	NULL
best	NULL
fit	NULL
for	NULL
a	NULL
consensus	NULL
sequence	NULL
for	NULL
NF-IL6	NULL
among	NULL
species	NULL
was	NULL
found	NULL
,	NULL
and	NULL
the	NULL
C/EBP	NULL
family	NULL
was	NULL
T	NULL
(	NULL
T/	NULL
G	NULL
)	NULL
NNGNAA	NULL
(	NULL
T/G	NULL
)	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
NF-IL6	NULL
cDNA	NULL
clone	NULL
from	NULL
Akira	NULL
and	NULL
colleagues	NULL
(	NULL
2	NULL
)	NULL
,	NULL
we	NULL
did	NULL
not	NULL
detect	NULL
this	NULL
specific	NULL
mRNA	NULL
in	NULL
stimulated	NULL
THP-1	NULL
cells	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
concept	NULL
that	NULL
there	NULL
is	NULL
a	NULL
family	NULL
of	NULL
nuclear	NULL
binding	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
NF-IL6	NULL
consensus	NULL
sequence	NULL
.	NULL

The	NULL
proteins	NULL
NF-	NULL
«	NULL
B-p50	NULL
and	NULL
NF-IL6	NULL
may	NULL
interact	NULL
by	NULL
using	NULL
common	NULL
leucine	NULL
zipper	NULL
motifs	NULL
to	NULL
enhance	NULL
transcription	NULL
of	NULL
cytokine	NULL
and	NULL
other	NULL
genes	NULL
involved	NULL
in	NULL
inflammation	NULL
(	NULL
29	NULL
)	NULL
.	NULL

As	NULL
macrophages	NULL
differentiated	NULL
to	NULL
more	NULL
mature	NULL
forms	NULL
,	NULL
there	NULL
was	NULL
a	NULL
striking	NULL
increase	NULL
in	NULL
NF-IL6	NULL
expression	NULL
(	NULL
34	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
LAM	NULL
from	NULL
M.	NULL
tuberculosis	NULL
activates	NULL
NF-IL6	NULL
,	NULL
triggering	NULL
a	NULL
cytokine	NULL
cascade	NULL
of	NULL
IL-1B	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
TNF-	NULL
«	NULL
release	NULL
attracting	NULL
macrophages	NULL
,	NULL
lymphocytes	NULL
,	NULL
and	NULL
neutrophils	NULL
to	NULL
sites	NULL
of	NULL
in-flammation	NULL
;	NULL
stimulating	NULL
cell-cell	NULL
adhesion	NULL
;	NULL
and	NULL
differentiating	NULL
macrophages	NULL
into	NULL
the	NULL
epithelioid	NULL
and	NULL
Langerhans	NULL
giant	NULL
cells	NULL
forming	NULL
a	NULL
typical	NULL
granuloma	NULL
.	NULL

Macrophages	NULL
are	NULL
major	NULL
participants	NULL
in	NULL
immune	NULL
defense	NULL
against	NULL
M.	NULL
tuberculosis	NULL
(	NULL
5	NULL
,	NULL
8	NULL
,	NULL
10	NULL
,	NULL
13	NULL
,	NULL
40	NULL
)	NULL
.	NULL

Cytokines	NULL
produced	NULL
by	NULL
macrophages	NULL
play	NULL
important	NULL
roles	NULL
in	NULL
manifestations	NULL
and	NULL
pathological	NULL
events	NULL
of	NULL
tuberculosis	NULL
,	NULL
especially	NULL
granuloma	NULL
formation	NULL
and	NULL
systemic	NULL
symptoms	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
of	NULL
how	NULL
the	NULL
expression	NULL
of	NULL
these	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

cytokine	NULL
genes	NULL
is	NULL
regulated	NULL
is	NULL
important	NULL
for	NULL
future	NULL
efforts	NULL
to	NULL
modulate	NULL
the	NULL
host	NULL
's	NULL
response	NULL
to	NULL
M.	NULL
tuberculosis	NULL
infection	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Jan	NULL
Viléek	NULL
for	NULL
critical	NULL
review	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
Laura	NULL
Sternberg	NULL
for	NULL
editorial	NULL
assistance	NULL
,	NULL
and	NULL
Patrick	NULL
Brennan	NULL
for	NULL
LAM	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
the	NULL
Aaron	NULL
Diamond	NULL
Foundation	NULL
and	NULL
grant	NULL
MOL	NULL
RRO0096-2851	NULL
for	NULL
support	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
T.	NULL
Taga	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Biology	NULL
of	NULL
multifunctional	NULL
cytokines	NULL
:	NULL
IL-6	NULL
and	NULL
related	NULL
molecules	NULL
(	NULL
IL-1	NULL
and	NULL
TNF	NULL
)	NULL
.	NULL

FASEB	NULL
J	NULL
.	NULL

4:2860-2867	NULL
.	NULL

2	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Isshiki	NULL
,	NULL
T.	NULL
Sugita	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
nuclear	NULL
factor	NULL
for	NULL
IL-6	NULL
expression	NULL
(	NULL
NF-IL6	NULL
)	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
C/EBP	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9:1897-1906	NULL
.	NULL

3	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1992	NULL
.	NULL

IL-6	NULL
and	NULL
NF-IL6	NULL
in	NULL
acute-phase	NULL
response	NULL
and	NULL
viral	NULL
infection	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

127:25-50	NULL
.	NULL

4	NULL
.	NULL

Auron	NULL
,	NULL
P.	NULL
E.	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
L.	NULL
J.	NULL
Rosenwasser	NULL
,	NULL
S.	NULL
F.	NULL
Mucci	NULL
,	NULL
A	NULL
.	NULL

Rich	NULL
,	NULL
S.	NULL
M.	NULL
Wolff	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1984	NULL
.	NULL

Nucleotide	NULL
sequence	NULL
of	NULL
human	NULL
monocyte	NULL
interleukin-1	NULL
precursor	NULL
cDNA	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
81:7907-7911	NULL
.	NULL

5	NULL
.	NULL

Barnes	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
D.	NULL
Chatterjee	NULL
,	NULL
J.	NULL
S.	NULL
Abrams	NULL
,	NULL
S.	NULL
Lu	NULL
,	NULL
E.	NULL
Wang	NULL
,	NULL
M.	NULL
Yamamura	NULL
,	NULL
P.	NULL
J.	NULL
Brennan	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Modlin	NULL
.	NULL

1992	NULL
.	NULL

Cytokine	NULL
production	NULL
induced	NULL
by	NULL
Mycobacterium	NULL
tuberculosis	NULL
lipoarabi-nomannan	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:541-547	NULL
.	NULL

6	NULL
.	NULL

Barnes	NULL
,	NULL
P.	NULL
F.	NULL
,	NULL
S.-J	NULL
.	NULL

Fong	NULL
,	NULL
P.	NULL
J.	NULL
Brennan	NULL
,	NULL
P.	NULL
E.	NULL
Twomey	NULL
,	NULL
A.	NULL
Mazumder	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Modlin	NULL
.	NULL

1990	NULL
.	NULL

Local	NULL
production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
IFN-y	NULL
in	NULL
tuberculous	NULL
pleuritis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

145:149-154	NULL
.	NULL

7	NULL
.	NULL

Bensi	NULL
,	NULL
G.	NULL
,	NULL
G.	NULL
Raugei	NULL
,	NULL
E.	NULL
Palla	NULL
,	NULL
V.	NULL
Carinci	NULL
,	NULL
D.	NULL
T.	NULL
Buonamassa	NULL
,	NULL
and	NULL
M.	NULL
Melli	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
interleukin-1	NULL
beta	NULL
gene	NULL
.	NULL

Gene	NULL
52:95-101	NULL
.	NULL

8	NULL
.	NULL

Bloom	NULL
,	NULL
B.	NULL
R.	NULL
,	NULL
and	NULL
C.	NULL
J.	NULL
L.	NULL
Murray	NULL
.	NULL

1992	NULL
.	NULL

Tuberculosis	NULL
:	NULL
commentary	NULL
on	NULL
a	NULL
reemergent	NULL
killer	NULL
.	NULL

Science	NULL
257:1055-1064	NULL
.	NULL

9	NULL
.	NULL

Cerretti	NULL
,	NULL
D.	NULL
P.	NULL
,	NULL
C.	NULL
J.	NULL
Kozlosky	NULL
,	NULL
B.	NULL
Mosley	NULL
,	NULL
N.	NULL
Nelson	NULL
,	NULL
K.	NULL
Van	NULL
Ness	NULL
,	NULL
T.	NULL
A.	NULL
Greenstreet	NULL
,	NULL
C.	NULL
J	NULL
.	NULL

March	NULL
,	NULL
S.	NULL
R.	NULL
Kronheim	NULL
,	NULL
T.	NULL
Druck	NULL
,	NULL
L.	NULL
A.	NULL
Cannizzaro	NULL
,	NULL
K.	NULL
Huebner	NULL
,	NULL
and	NULL
R.	NULL
A	NULL
.	NULL

Black	NULL
.	NULL

1992	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
interleukin-1B	NULL
converting	NULL
enzyme	NULL
.	NULL

Science	NULL
256	NULL
:	NULL
97-100	NULL
.	NULL

10	NULL
.	NULL

Chan	NULL
,	NULL
J.	NULL
,	NULL
X	NULL
.	NULL

Fan	NULL
,	NULL
S.	NULL
W.	NULL
Hunter	NULL
,	NULL
P.	NULL
J.	NULL
Brennan	NULL
,	NULL
and	NULL
B.	NULL
R.	NULL
Bloom	NULL
.	NULL

1991	NULL
.	NULL

Lipoarabinomannan	NULL
,	NULL
a	NULL
possible	NULL
virulence	NULL
factor	NULL
involved	NULL
in	NULL
persistence	NULL
of	NULL
Mycobacterium	NULL
tuberculosis	NULL
within	NULL
macrophages	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

59:1755-1761	NULL
.	NULL

11	NULL
.	NULL

Chatterjee	NULL
,	NULL
D.	NULL
,	NULL
K.	NULL
Lowell	NULL
,	NULL
B.	NULL
Rivoire	NULL
,	NULL
M.	NULL
R.	NULL
McNeil	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Brennan	NULL
.	NULL

1992	NULL
.	NULL

Lipoarabinomannan	NULL
of	NULL
Mycobacterium	NULL
tuberculosis	NULL
.	NULL

Capping	NULL
with	NULL
mannosyl	NULL
residues	NULL
in	NULL
some	NULL
strains	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:6234-6239	NULL
.	NULL

12	NULL
.	NULL

Chatterjee	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
D.	NULL
Roberts	NULL
,	NULL
K.	NULL
Lowell	NULL
,	NULL
P.	NULL
J.	NULL
Brennan	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Orme	NULL
.	NULL

1992	NULL
.	NULL

Structural	NULL
basis	NULL
of	NULL
capacity	NULL
of	NULL
lipoarabinomannan	NULL
to	NULL
induce	NULL
secretion	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

60:1249-1253	NULL
.	NULL

13	NULL
.	NULL

Chensue	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
M.	NULL
P.	NULL
Davey	NULL
,	NULL
D.	NULL
G.	NULL
Remick	NULL
,	NULL
and	NULL
S.	NULL
Kunkel	NULL
.	NULL

1986	NULL
.	NULL

Release	NULL
of	NULL
interleukin-1	NULL
by	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
cells	NULL
in	NULL
patients	NULL
with	NULL
tuberculosis	NULL
and	NULL
active	NULL
inflammation	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

§2:341-343	NULL
.	NULL

14	NULL
.	NULL

Clark	NULL
,	NULL
B.	NULL
D.	NULL
,	NULL
K.	NULL
L.	NULL
Collins	NULL
,	NULL
M.	NULL
S.	NULL
Gandy	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1986	NULL
.	NULL

Genomic	NULL
sequence	NULL
for	NULL
human	NULL
prointerleukin	NULL
1	NULL
beta	NULL
:	NULL
possible	NULL
evolution	NULL
from	NULL
a	NULL
reverse	NULL
transcribed	NULL
prointerleu-kin-1	NULL
alpha	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:7897-7914	NULL
.	NULL

15	NULL
.	NULL

Crump	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
L.	NULL
J.	NULL
Geist	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
require	NULL
only	NULL
proximal	NULL
promoter	NULL
elements	NULL
to	NULL
upregulate	NULL
expression	NULL
of	NULL
interleukin-1B	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

6:674-677	NULL
.	NULL

16	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
R.	NULL
M.	NULL
Lebovitz	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1983	NULL
.	NULL

Accurate	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
in	NULL
a	NULL
soluble	NULL
extract	NULL
from	NULL
isolated	NULL
mammalian	NULL
nuclei	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11:1475-1489	NULL
.	NULL

17	NULL
.	NULL

Dunn	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
H.	NULL
Gibbons	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
recombinant	NULL
interleukin-1	NULL
induces	NULL
chronic	NULL
granulomatous	NULL
inflammation	NULL
.	NULL

J.	NULL
Leukocyte	NULL
Biol	NULL
.	NULL

42:615	NULL
.	NULL

Vor	NULL
.	NULL

13	NULL
,	NULL
1993	NULL
18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Fenton	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
M.	NULL
W.	NULL
Vermeulen	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
A.	NULL
C.	NULL
Webb	NULL
,	NULL
and	NULL
P.	NULL
E.	NULL
Auron	NULL
.	NULL

1987	NULL
.	NULL

Human	NULL
Pro-IL-18	NULL
gene	NULL
expression	NULL
in	NULL
monocytic	NULL
cells	NULL
is	NULL
regulated	NULL
by	NULL
two	NULL
distinct	NULL
pathways	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:2267-2273	NULL
.	NULL

Fujita	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Shubiya	NULL
,	NULL
T.	NULL
Ohashi	NULL
,	NULL
K.	NULL
Yamanishi	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1986	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
interleukin-2	NULL
gene	NULL
:	NULL
functional	NULL
DNA	NULL
sequences	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
for	NULL
the	NULL
gene	NULL
expression	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
46:401-407	NULL
.	NULL

Furutani	NULL
,	NULL
Y.	NULL
,	NULL
M.	NULL
Notake	NULL
,	NULL
T.	NULL
Fukui	NULL
,	NULL
M.	NULL
Ohue	NULL
,	NULL
H.	NULL
Nomura	NULL
,	NULL
M.	NULL
Yamada	NULL
,	NULL
and	NULL
S.	NULL
Nakamura	NULL
.	NULL

1986	NULL
.	NULL

Complete	NULL
nucleotide	NULL
sequence	NULL
of	NULL
the	NULL
gene	NULL
for	NULL
human	NULL
interleukin-1	NULL
alpha	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

14:3167-3179	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
L.	NULL
F.	NULL
Moffat	NULL
,	NULL
and	NULL
B.	NULL
H.	NULL
Howard	NULL
.	NULL

1982	NULL
.	NULL

Recombinant	NULL
genomes	NULL
which	NULL
express	NULL
chloramphenicol	NULL
acetyltransferase	NULL
in	NULL
mammalian	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2:1044-1051	NULL
.	NULL

Hunninghake	NULL
,	NULL
G.	NULL
W.	NULL
,	NULL
M.	NULL
D.	NULL
Monick	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Dinarello	NULL
.	NULL

1987	NULL
.	NULL

Interleukin-1	NULL
is	NULL
a	NULL
chemotactic	NULL
factor	NULL
for	NULL
human	NULL
T-lymphocytes	NULL
.	NULL

Am	NULL
.	NULL

Rev	NULL
.	NULL

Respir	NULL
.	NULL

Dis	NULL
.	NULL

135:66-71	NULL
.	NULL

Isshiki	NULL
,	NULL
H.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
O.	NULL
Tanabe	NULL
,	NULL
T.	NULL
Nakajima	NULL
,	NULL
T.	NULL
Shimamoto	NULL
,	NULL
T.	NULL
Hirano	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Constitutive	NULL
and	NULL
interleukin-1	NULL
(	NULL
IL-1	NULL
)	NULL
-inducible	NULL
factors	NULL
interact	NULL
with	NULL
the	NULL
IL-l-responsive	NULL
element	NULL
in	NULL
the	NULL
IL-6	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:2757-2764	NULL
.	NULL

Iwamoto	NULL
,	NULL
G.	NULL
K.	NULL
,	NULL
M.	NULL
M.	NULL
Monick	NULL
,	NULL
B.	NULL
D.	NULL
Clark	NULL
,	NULL
P.	NULL
E.	NULL
Auron	NULL
,	NULL
M.	NULL
F.	NULL
Stinski	NULL
,	NULL
and	NULL
G.	NULL
W.	NULL
Hunninghake	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin-1	NULL
beta	NULL
gene	NULL
expression	NULL
by	NULL
the	NULL
immediate	NULL
early	NULL
genes	NULL
of	NULL
human	NULL
cytomegalovirus	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1853-1857	NULL
.	NULL

Kindler	NULL
,	NULL
V.	NULL
,	NULL
A.-P.	NULL
Sappino	NULL
,	NULL
G.	NULL
E.	NULL
Grau	NULL
,	NULL
P.-F.	NULL
Piguet	NULL
,	NULL
and	NULL
P.	NULL
Vassalli	NULL
.	NULL

1989	NULL
.	NULL

The	NULL
inducing	NULL
role	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
in	NULL
the	NULL
development	NULL
of	NULL
bactericidal	NULL
granulomas	NULL
during	NULL
BCG	NULL
infection	NULL
.	NULL

Cell	NULL
56:731-740	NULL
.	NULL

Kobayashi	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
Allred	NULL
,	NULL
S.	NULL
Cohen	NULL
,	NULL
and	NULL
T.	NULL
Yoshida	NULL
.	NULL

1984	NULL
.	NULL

Role	NULL
of	NULL
interleukin-1	NULL
in	NULL
experimental	NULL
pulmonary	NULL
granuloma	NULL
in	NULL
mice	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

134:358-363	NULL
.	NULL

Kunkel	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
S.	NULL
W.	NULL
Chensue	NULL
,	NULL
R.	NULL
M.	NULL
Strieter	NULL
,	NULL
J.	NULL
P.	NULL
Lynch	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Remick	NULL
.	NULL

1989	NULL
.	NULL

Cellular	NULL
and	NULL
molecular	NULL
aspects	NULL
of	NULL
granulomatous	NULL
inflammation	NULL
.	NULL

Am	NULL
.	NULL

J.	NULL
Respir	NULL
.	NULL

Cell	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

1:439-447	NULL
.	NULL

Le	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
Vilcek	NULL
.	NULL

1987	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
and	NULL
interleu-kin-1	NULL
:	NULL
cytokines	NULL
with	NULL
multiple	NULL
overlapping	NULL
biological	NULL
activities	NULL
.	NULL

Lab	NULL
.	NULL

Invest	NULL
.	NULL

56:234-248	NULL
.	NULL

LeClair	NULL
,	NULL
K.	NULL
P.	NULL
,	NULL
M.	NULL
A.	NULL
Blanar	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
p50	NULL
subunit	NULL
of	NULL
NF-kB	NULL
associates	NULL
with	NULL
the	NULL
NF-IL6	NULL
transcription	NULL
factor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:8145-8149	NULL
.	NULL

Loppnow	NULL
,	NULL
H.	NULL
,	NULL
L.	NULL
Brade	NULL
,	NULL
H.	NULL
Brade	NULL
,	NULL
E.	NULL
T.	NULL
Rietschel	NULL
,	NULL
S.	NULL
Kusumoto	NULL
,	NULL
T.	NULL
Shiba	NULL
,	NULL
and	NULL
H.-D.	NULL
Flad	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
human	NULL
interleukin-1	NULL
by	NULL
bacterial	NULL
and	NULL
synthetic	NULL
lipid	NULL
A.	NULL
Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

16:1263-1267	NULL
.	NULL

March	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
B.	NULL
Mosley	NULL
,	NULL
A.	NULL
Larsen	NULL
,	NULL
D.	NULL
P.	NULL
Cerretti	NULL
,	NULL
G.	NULL
Braedt	NULL
,	NULL
V.	NULL
Price	NULL
,	NULL
S.	NULL
Gillis	NULL
,	NULL
C.	NULL
S.	NULL
Henney	NULL
,	NULL
S.	NULL
R.	NULL
Kronheim	NULL
,	NULL
K.	NULL
Grabstein	NULL
,	NULL
P.	NULL
J.	NULL
Conion	NULL
,	NULL
T.	NULL
P.	NULL
Hopp	NULL
,	NULL
and	NULL
D.	NULL
Cosman	NULL
.	NULL

1985	NULL
.	NULL

Cloning	NULL
,	NULL
sequence	NULL
and	NULL
expression	NULL
of	NULL
two	NULL
distinct	NULL
human	NULL
interleukin-1	NULL
complementary	NULL
DNAs	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
315:641-647	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
,	NULL
A.	NULL
Mehlert	NULL
,	NULL
and	NULL
J.	NULL
Lamb	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
inhibitory	NULL
33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

IL-18	NULL
GENE	NULL
REGULATION	NULL
BY	NULL
NF-IL6	NULL
MOTIFS	NULL
3837	NULL
effects	NULL
of	NULL
mycobacterial	NULL
lipoarabinomannan	NULL
and	NULL
polysaccha-rides	NULL
upon	NULL
polyclonal	NULL
and	NULL
monoclonal	NULL
human	NULL
T	NULL
cell	NULL
prolifera-tion	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

74:206-210	NULL
.	NULL

Moreno	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Taverne	NULL
,	NULL
A.	NULL
Mehlert	NULL
,	NULL
C.	NULL
A.	NULL
W.	NULL
Bate	NULL
,	NULL
R.	NULL
J.	NULL
Brealey	NULL
,	NULL
A	NULL
.	NULL

Meager	NULL
,	NULL
G.	NULL
A.	NULL
W.	NULL
Rook	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
L.	NULL
Playfair	NULL
.	NULL

1989	NULL
.	NULL

Lipoarabinomannan	NULL
from	NULL
Mycobacterium	NULL
tuberculosis	NULL
induces	NULL
the	NULL
production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
from	NULL
human	NULL
and	NULL
murine	NULL
macrophages	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

76:240-245	NULL
.	NULL

Natsuka	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Akira	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1992	NULL
.	NULL

Macrophage	NULL
differentiation-specific	NULL
expression	NULL
of	NULL
NF-IL6	NULL
,	NULL
a	NULL
transcription	NULL
factor	NULL
for	NULL
interleukin-6	NULL
.	NULL

Blood	NULL
79:460-466	NULL
.	NULL

Nawroth	NULL
,	NULL
P.	NULL
P.	NULL
,	NULL
I	NULL
.	NULL

Bank	NULL
,	NULL
D.	NULL
Handley	NULL
,	NULL
J.	NULL
Cassimeris	NULL
,	NULL
L.	NULL
Chess	NULL
,	NULL
and	NULL
D.	NULL
Stern	NULL
.	NULL

1986	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor/cachectin	NULL
interacts	NULL
with	NULL
endothelial	NULL
cell	NULL
receptors	NULL
to	NULL
induce	NULL
release	NULL
of	NULL
interleukin-1	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

163:1363-1375	NULL
.	NULL

Riesenfeld-Orn	NULL
,	NULL
I.	NULL
,	NULL
S.	NULL
Wolpe	NULL
,	NULL
J.	NULL
F.	NULL
Garcia-Bustos	NULL
,	NULL
M.	NULL
K.	NULL
Hoff-mann	NULL
,	NULL
and	NULL
E.	NULL
Tuomanen	NULL
.	NULL

1989	NULL
.	NULL

Production	NULL
of	NULL
interleukin-1	NULL
but	NULL
not	NULL
tumor	NULL
necrosis	NULL
factor	NULL
by	NULL
human	NULL
monocytes	NULL
stimulated	NULL
with	NULL
pneumococcal	NULL
cell	NULL
surface	NULL
components	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

57	NULL
:	NULL
1890-1893	NULL
.	NULL

Sen	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
D.	NULL
Baltimore	NULL
.	NULL

1986	NULL
.	NULL

Inducibility	NULL
of	NULL
«	NULL
k	NULL
immunoglob-ulin	NULL
enhancer-binding	NULL
protein	NULL
NF-	NULL
«	NULL
B	NULL
by	NULL
a	NULL
post	NULL
translational	NULL
mechanism	NULL
.	NULL

Cell	NULL
47:921-928	NULL
.	NULL

Shinnick	NULL
,	NULL
T.	NULL
M.	NULL
,	NULL
M.	NULL
H.	NULL
Vodkin	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Williams	NULL
.	NULL

1988	NULL
.	NULL

The	NULL
Mycobacterium	NULL
tuberculosis	NULL
65-kilodalton	NULL
antigen	NULL
is	NULL
a	NULL
heat	NULL
shock	NULL
protein	NULL
which	NULL
corresponds	NULL
to	NULL
common	NULL
antigen	NULL
and	NULL
to	NULL
the	NULL
Escherichia	NULL
coli	NULL
GroEL	NULL
protein	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

56:446-451	NULL
.	NULL

Sibley	NULL
,	NULL
L.	NULL
D.	NULL
,	NULL
S.	NULL
W.	NULL
Hunter	NULL
,	NULL
P.	NULL
J.	NULL
Brennan	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Krahen-buhl	NULL
.	NULL

1988	NULL
.	NULL

Mycobacterial	NULL
lipoarabinomannan	NULL
inhibits	NULL
gamma	NULL
interferon-mediated	NULL
activation	NULL
of	NULL
macrophages	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

56:1232-1236.	NULL
.	NULL

Takashima	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
Ueta	NULL
,	NULL
I.	NULL
Tsuyuguchi	NULL
,	NULL
and	NULL
S.	NULL
Kishimoto	NULL
.	NULL

1990	NULL
.	NULL

Production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
by	NULL
monocytes	NULL
from	NULL
patients	NULL
with	NULL
pulmonary	NULL
tuberculosis	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

58:3286-3292	NULL
.	NULL

Wallis	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
M.	NULL
Amir-Tahmasseb	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Eliner	NULL
.	NULL

1990	NULL
.	NULL

Induction	NULL
of	NULL
interleukin-1	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor	NULL
by	NULL
mycobacterial	NULL
proteins	NULL
:	NULL
the	NULL
monocyte	NULL
Western	NULL
blot	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:3348-3352	NULL
.	NULL

Yamato	NULL
,	NULL
K.	NULL
,	NULL
Z.	NULL
Ei-Hajjaoui	NULL
,	NULL
K.	NULL
Simon	NULL
,	NULL
and	NULL
H.	NULL
P.	NULL
Koeffler	NULL
.	NULL

1990	NULL
.	NULL

Modulation	NULL
of	NULL
interleukin-1B	NULL
RNA	NULL
in	NULL
monocytic	NULL
cells	NULL
infected	NULL
with	NULL
human	NULL
immunodeficiency	NULL
virus-1	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

86:1109-1114	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
T.	NULL
C.	NULL
Lee	NULL
,	NULL
B.	NULL
Guillemin	NULL
,	NULL
M.	NULL
C.	NULL
Yu	NULL
,	NULL
and	NULL
W.	NULL
N.	NULL
Rom	NULL
.	NULL

Enhanced	NULL
interleukin-1B	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
release	NULL
and	NULL
mRNA	NULL
expression	NULL
in	NULL
macrophages	NULL
from	NULL
idiopathic	NULL
pulmonary	NULL
fibrosis	NULL
or	NULL
following	NULL
asbestos	NULL
exposure	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
in	NULL
press	NULL
.	NULL

.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
W.	NULL
N.	NULL
Rom	NULL
.	NULL

1992	NULL
.	NULL

Lipoarabinomannan	NULL
from	NULL
Mycobacterium	NULL
tuberculosis	NULL
activates	NULL
NF-IL-6	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
on	NULL
the	NULL
interleukin-6	NULL
gene	NULL
.	NULL

Clin	NULL
.	NULL

Res	NULL
.	NULL

40:215A	NULL
.	NULL

